WO2007116863A1 - Medicinal-liquid injection system - Google Patents

Medicinal-liquid injection system Download PDF

Info

Publication number
WO2007116863A1
WO2007116863A1 PCT/JP2007/057411 JP2007057411W WO2007116863A1 WO 2007116863 A1 WO2007116863 A1 WO 2007116863A1 JP 2007057411 W JP2007057411 W JP 2007057411W WO 2007116863 A1 WO2007116863 A1 WO 2007116863A1
Authority
WO
WIPO (PCT)
Prior art keywords
chemical
cylinder
syringe
rfid tag
holding
Prior art date
Application number
PCT/JP2007/057411
Other languages
French (fr)
Japanese (ja)
Inventor
Shigeru Nemoto
Masahiro Sakakibara
Original Assignee
Nemoto Kyorindo Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nemoto Kyorindo Co., Ltd. filed Critical Nemoto Kyorindo Co., Ltd.
Priority to JP2008509836A priority Critical patent/JP5063591B2/en
Publication of WO2007116863A1 publication Critical patent/WO2007116863A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/007Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests for contrast media
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/145Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • A61M5/1452Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
    • A61M5/14546Front-loading type injectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/35Communication
    • A61M2205/3546Range
    • A61M2205/3569Range sublocal, e.g. between console and disposable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/35Communication
    • A61M2205/3576Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3592Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/60General characteristics of the apparatus with identification means
    • A61M2205/6054Magnetic identification systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/145Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • A61M5/1452Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
    • A61M5/1456Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons with a replaceable reservoir comprising a piston rod to be moved into the reservoir, e.g. the piston rod is part of the removable reservoir

Definitions

  • the present invention relates to a chemical solution injection system for injecting a chemical solution of a chemical solution syringe into a subject with a chemical solution injection device.
  • the present invention relates to a chemical injection system that injects a contrast medium into a subject whose fluoroscopic image is captured by a fluoroscopic imaging device such as a scanner.
  • a fluoroscopic imaging device for imaging a fluoroscopic image of a subject
  • a CT scanner an MRI (Magnetic Resonance Imaging) device
  • MRI Magnetic Resonance Imaging
  • PET PET
  • ultrasonic diagnostic device a CT angiography device
  • MRA MRA
  • Angio equipment, etc.
  • a chemical solution such as a contrast medium or physiological saline may be injected into the subject, and a chemical injection device that automatically performs this injection has also been put into practical use! .
  • Such a chemical solution injection device has, for example, a piston drive mechanism including a drive motor and a slider mechanism, and a chemical solution syringe is detachably attached thereto.
  • the chemical syringe generally has a cylinder member and a piston member, and the piston member is slidably inserted into the cylinder member.
  • the cylinder member has a cylindrical cylinder body, and a conduit portion is formed at the center of the closed front end.
  • the rear end of the cylinder body is opened, and a piston member is inserted into the inside through the opening.
  • An annular cylinder flange is formed on the outer periphery of the rear end of the cylinder body.
  • Such a liquid syringe includes a prefilled type and a post-filling type.
  • the pre-filled type is shipped with the cylinder member filled with chemicals and sealed entirely with packing material.
  • a post-filling type a cylinder member is filled with a desired chemical solution by a user.
  • the chemical syringe is a prefilled type.
  • the chemical injection device press-fits the piston member into the cylinder member by the piston drive mechanism in response to a predetermined operation.
  • the drug solution is injected into the subject by the drug syringe force.
  • the chemical solution injection device supplies the chemical solution corresponding to the input data. Inject the subject. For example, if a contrast medium is injected as a chemical solution, the contrast level of the subject changes, and a good fluoroscopic image is captured by the fluoroscopic imaging device.
  • a force chemical liquid injection device having a high viscosity contrast medium is suitable for injecting a contrast medium because a piston member can be pushed into a cylinder member of a chemical liquid syringe at a high pressure.
  • a piston member can be pushed into a cylinder member of a chemical liquid syringe at a high pressure.
  • the chemical injection device implemented by the present applicant has a pair of left and right metal flange holding members, and the flange holding member can be freely opened and closed by the metal main body holding member. I support it.
  • the main body holding member has a holding recess formed on the upper surface, and holds the cylinder main body inserted from the upper side by the holding recess.
  • the pair of left and right flange holding members are formed with holding slits on the inner surfaces facing each other, and hold the left and right portions of the cylinder flange of the chemical syringe inserted from above in an open state in a closed state.
  • Patent Document 1 Japanese Patent Application Laid-Open No. 2004-154238
  • Patent Document 2 JP 2004-154239 A
  • Patent Document 3 JP 2004-187849
  • Patent Document 4 Japanese Patent Application Laid-Open No. 2004-243009
  • Patent Document 5 Japanese Patent Application Laid-Open No. 2004-290454
  • the cylinder flange of the chemical syringe can be firmly held by the metal flange holding member. Therefore, a high viscosity contrast agent is formed by pushing the piston member into the cylinder member of the chemical syringe at a high pressure. Can be successfully injected into a subject. Moreover, since the flange holding member that can be opened and closed is supported by the metal main body holding member, even if a large amount of stress acts on the chemical liquid syringe force flange holding member, for example, the main body holding member may be deformed or damaged. Don't do it.
  • a flat portion is formed on a part of the outer peripheral surface of the cylinder flange in order to prevent unnecessary rolling and the like.
  • the flat portion is usually formed in a shape obtained by partially cutting the circular outer peripheral surface of the cylinder flange in a straight line, and is formed in parallel so as to be paired with the opposite position of the outer peripheral surface of the cylinder flange. ing. Therefore, the above-described chemical injection device is configured to hold a circular portion, which is not a flat portion of the cylinder flange, with a flange holding member. Therefore, the operator needs to hold the cylinder flange on the flange holding member at the position of the circular portion.
  • the present applicant's power application 2004-110853 (WO2005Z097232A1)
  • a pattern that has a predetermined shape when viewed from above through a cylinder member filled with a transparent chemical solution is formed on the lower surface of the cylinder member and the inner surface of the holding recess of the main body holding member. It is divided into two.
  • the upward force of the cylinder member is visually recognized as a predetermined shape only when the chemical solution syringe filled with the chemical solution is properly attached to the chemical solution injection device.
  • this visual recognition it is possible to confirm both that the chemical syringe is appropriately held and that the cylinder member is filled with the chemical solution at a time.
  • the chemical solution is injected into the subject from the chemical solution syringe.
  • the operator needs to select an appropriate chemical solution syringe. is there.
  • the operator since there are products with the same or similar appearance even if the type of the chemical solution is different, there is a possibility that the operator may attach the chemical syringe of the chemical solution to the chemical injection device.
  • a product that is not a compatible product may be used as a chemical syringe, and a medical accident may occur due to inadequate performance such as pressure resistance.
  • prefilled type drug syringes are discarded after a single use in order to prevent infection, but current drug injectors cannot prevent a drug syringe once used from being used again. .
  • the present invention has been made in view of the above-described problems, and the flange holding member appropriately holds the chemical syringe, and automatically prevents the piston drive mechanism from being driven in this state.
  • An object of the present invention is to provide a chemical solution injection system that can be used.
  • the chemical solution injection system of the present invention includes a chemical solution syringe and a chemical solution injection device.
  • the chemical syringe includes a cylinder member having a cylinder flange formed on the outer periphery of the rear end of the cylinder body, and a piston member that is slidably inserted into the cylinder member in a backward direction.
  • the chemical injection device pushes the piston member into the cylinder member of the chemical syringe and injects the chemical into the subject.
  • the chemical syringe has an RFID tag mounted on the outer peripheral surface of the cylinder body.
  • the RFID tag has a circuit chip and a planar loop antenna connected to the circuit chip, and wirelessly transmits recording data by electromagnetic induction.
  • the chemical liquid injector includes a main body holding member, a flange holding member, a piston drive mechanism, an RFID reader, an operation control means, and an antenna sheet.
  • the main body holding member is made of metal, and holds the cylinder main body inserted from above by the holding recess.
  • the flange holding member is made of metal and supported by the main body holding member, and holds the cylinder flange inserted from the upper side.
  • the piston drive mechanism pushes the piston member into the cylinder member held together with the cylinder flange.
  • the RFID reader wirelessly receives the RFID tag recording data by electromagnetic induction.
  • the operation control means controls the operation of the piston drive mechanism in response to the wireless reception of the recording data.
  • the antenna sheet has an elongated loop antenna.
  • a through hole is formed in the main body holding member from the outer surface to the inner surface of the holding recess.
  • the RFID reader is arranged at a position adjacent to the through hole on the outer surface of the holding recess.
  • One end of the antenna sheet passed through the through hole of the holding recess is disposed on the inner surface of the holding recess, and the other end faces the RFID reader.
  • the RFID tag is parallel to one end of the antenna sheet by properly attaching the chemical syringe to the chemical injection device. It can be made to face.
  • the RFID tag and the antenna sheet as described above can be formed in a substantially rectangular sheet shape, for example.
  • the antenna sheet can be formed as a structure corresponding to an R FID tag in which the circuit chip is omitted.
  • RFID tags and antenna sheets are approved as communication devices of the unified standard and are mass-produced as off-the-shelf products.
  • the RFID tag can be made to face the one end of the antenna sheet in parallel by appropriately attaching the chemical syringe to the chemical injection device. It is possible to easily and reliably detect whether a chemical syringe is properly attached to the chemical injection device using the existing antenna sheet.
  • the various means referred to in the present invention are preferably provided so as to realize their functions.
  • dedicated hardware that exhibits a predetermined function and a predetermined function are given by a computer program.
  • the data processing device, a predetermined function implemented in the data processing device by a computer program, a combination thereof, and the like can be realized.
  • a plurality of constituent elements that do not need to be independent from each other are formed as one member, and one constituent element includes a plurality of members. It is possible that a component is a part of another component, a part of a component overlaps a part of another component, etc. is there.
  • the front-rear direction and the up-down direction are defined, but this is defined for convenience in order to briefly explain the relative relationship of the constituent elements of the present invention. It does not limit the direction of production or use when it is implemented.
  • the one end, the other end, the left end, and the right end of the antenna sheet referred to in the present invention mean a portion from the outermost edge in the longitudinal direction to an arbitrary range, such as a substantially square portion. Good.
  • FIG. 1 is a schematic longitudinal side view of a main part showing a state in which a chemical syringe is attached to an injection head of a chemical injection device according to an embodiment of the present invention.
  • FIG. 2 is a perspective view showing a state in which a chemical syringe is attached to an injection head.
  • ⁇ 3] It is a perspective view showing the appearance of the chemical liquid injector.
  • FIG. 5 is a block diagram showing a circuit structure of the chemical solution injection system.
  • FIG. 6 is a perspective view showing an appearance of a chemical syringe.
  • FIG. 7 is a schematic perspective view showing the appearance of the RFID tag.
  • FIG. 8 is a schematic front view of the main part showing a state in which the chemical syringe is attached to the injection head.
  • FIG. 9 is a block diagram showing a logical structure of the chemical liquid injector.
  • FIG. 10 is a flowchart showing the first half of the processing operation of the chemical liquid injector.
  • FIG. 11 is a flowchart showing the latter half of the processing operation of the chemical injection device.
  • FIG. 12 is a flowchart showing the processing operation of the CT scanner.
  • FIG. 13 is a perspective view showing a modification of the injection head.
  • the chemical injection system 1000 of this embodiment includes a chemical injection device 100, a chemical syringe 200, and a CT scanner 300 that is a fluoroscopic imaging device. As will be described later, a fluoroscopic image is taken from a subject (not shown) who injects a medical solution such as a contrast medium.
  • the CT scanner 300 includes a fluoroscopic imaging unit 301 and an imaging control unit 302, as shown in FIGS.
  • the fluoroscopic imaging unit 301 and the imaging control unit 302 are wiredly connected via a communication network 303.
  • the fluoroscopic imaging unit 301 captures a fluoroscopic image from the subject, and the imaging control unit 302 controls the operation of the fluoroscopic imaging unit 301.
  • the chemical syringe 200 has a cylinder member 210 and a piston member 220, and the piston member 220 is slidably inserted into the cylinder member 210.
  • the cylinder member 210 has a cylindrical cylinder body 211, and a conduit portion 212 is formed at the closed front end of the cylinder body 211.
  • the rear end of the cylinder body 211 of the cylinder member 210 is opened, and the piston member 220 is inserted into the cylinder body 211 from this opening.
  • the cylinder member 210 has an annular cylinder flange 213 formed on the outer periphery of the rear end of the cylinder body 211, and the piston member 220 is an annular piston formed on the outer periphery of the piston body 221. It has flange 222.
  • the cylinder member 210 is formed of a non-conductive and non-magnetic resin, and has a thickness of about 1.5 mm to 2.0 mm, for example.
  • the chemical solution injection system 1000 of this embodiment at least a part of the chemical solution syringe 200 used is a prefilled type.
  • the pre-filled type chemical solution syringe 200 is shipped with the cylinder member 210 filled with the chemical solution.
  • the RFID tag 230 is attached to the cylinder member 210 of the chemical syringe 200.
  • the RFID tag 230 includes the name, prefilled type force refilter identification data, identification data for each individual, capacity, cylinder member 210 pressure resistance, cylinder member 210 inner diameter, and piston member 220 stroke. Various data such as, etc. are recorded.
  • the RFID tag 230 has a name, component, viscosity, expiration date, identification data such as whether it is for CT or MR, etc. Various data are also recorded. Further, when the drug solution filled in the prefilled type drug solution syringe 200 is a contrast medium, a variable pattern that changes the injection rate with time is recorded in the RFID tag 230 as necessary.
  • the RFID tag 230 has a long and narrow resin sheet 231, and a circuit chip 232 is enclosed in the vicinity of one end thereof.
  • the tag antenna 233 is also formed on the resin sheet 231 by a printed wiring as a planar and elongated loop antenna. It is.
  • the tag antenna 233 is connected to the circuit chip 232.
  • the surface of the resin sheet 231 is formed in white, and various information can be printed on this surface.
  • An adhesive material (not shown) is applied to the back surface of the resin sheet 231, and the RFID tag 230 can be attached to the outer peripheral surface of the cylinder member 210 with the adhesive material.
  • the chemical syringe 200 has a pair of flat portions 215 formed in parallel at opposite positions of the circular outer peripheral surface 214 of the cylinder flange 213.
  • the cylinder flange 213 has a left-right symmetry and a vertically symmetrical structure.
  • this chemical syringe 200 has, for example, a sticker with a message such as "Please use this as the upper side” or "Do not use this as the upper side”.
  • a sticker with a message such as "Please use this as the upper side” or "Do not use this as the upper side”.
  • the RFID tag 230 has a longitudinal direction parallel to the axial direction of the cylinder member 210, and the bottom of the cylinder body 211. It is mounted on the outer peripheral surface.
  • the drug solution injection device 100 of the present embodiment includes an injection head 110 and an injection control unit 101 that are configured separately from each other and are wire-connected by a communication cable 102.
  • the injection head 110 drives the chemical solution syringe 200 to be attached to inject the chemical solution into the subject.
  • the injection control unit 101 controls the operation of the injection head 110.
  • the injection head 110 is attached to the upper end of the caster stand 111 via the movable arm 112, and as shown in FIG.
  • the injection head 110 has a head housing 113 as an exterior.
  • the head housing 113 is entirely formed of a resin, but as shown in FIGS. 1 and 2, only the upper part of the front end is formed of a metal main body holding member 114.
  • the main body holding member 114 is formed of a high-strength nonmagnetic metal such as an aluminum alloy, and has a semi-cylindrical shape that holds the cylinder main body 211 inserted from the upper side.
  • the holding recess 115 is formed on the upper surface.
  • a cylinder holding mechanism 120 is disposed at the rear end of the main body holding member 114. Cylinder holding mechanism 120 is stainless steel alloy etc. It is made of high strength metal.
  • This cylinder holding mechanism 120 has a pair of left and right flange holding members 121.
  • the pair of left and right flange holding members 121 includes a fixed holding member 122 and a movable holding member 123.
  • the fixed holding member 122 is fixed to the rear end of the main body holding member 114, and the movable holding member 123 is supported by the rear end of the main body holding member 114 so as to be opened and closed in the left-right direction.
  • the fixed holding member 122 and the movable holding member 123 are formed with arc-shaped holding slits on the inner surface, and the cylinder flange 213 of the drug solution syringe 200 is engaged therewith.
  • a piston drive mechanism 116 is mounted on the rear portion of the injection head 110.
  • the piston driving mechanism 116 holds the piston flange 222 of the chemical syringe 200 and slides it back and forth.
  • the piston drive mechanism 116 has a drive motor 117 such as an AC (Alternating Current) motor as a drive source, and the piston member 220 is slid by a ball screw mechanism (not shown) or the like. Move.
  • AC Alternating Current
  • the piston drive mechanism 116 also includes a load cell 118.
  • the load cell 118 detects the pressure that presses the piston member 220.
  • a long and narrow metal frame (not shown) is disposed on the left and right sides of the head housing 113, and the piston drive mechanism 116 and the main body holding member 114 are connected by the metal frame.
  • the chemical injection device 100 includes, for example, an RFID reader 130 formed as a chip component having a reader antenna (not shown) mounted on the surface thereof. As shown in FIG. 1, the RFID reader 130 is disposed on the lower surface of the main body holding member 114 so that the reader antenna is positioned on the lower side.
  • the chemical injection device 100 of this embodiment has an antenna sheet 131.
  • the antenna sheet 131 has a structure corresponding to the RFID tag 230 from which the circuit chip 232 is omitted. That is, the antenna sheet 131 is formed as an off-the-shelf product together with an RFID tag 230 in which a planar loop antenna is formed into a slender shape with printed wiring on a slender resin sheet.
  • the antenna sheet 131 and the RFID tag 230 are formed in a substantially rectangular shape of 18 mm ⁇ 50 mm, for example, and include an MM tag (product name) that performs wireless communication at a frequency of 13.56 MHz.
  • the main body holding member 114 has the holding recess 115. From the outer surface (lower surface) to the inner surface (bottom surface), a horizontally long through-hole 133 that penetrates the holding recess 115 in the thickness direction is formed. The antenna sheet 131 is passed through the through hole 133.
  • One end located above the through hole 133 of the antenna sheet 131 is bent backward, and is disposed on the bottom surface of the holding recess 115 via a ferrite sheet 135 that is a sheet-like high-permeability ferromagnetic material. Has been. For this reason, when the chemical syringe 200 is properly attached to the force injection head 110, which will be described in detail later, one end of the antenna sheet 131 is placed at a position where the RFID tag 230 is parallelly opposed and well electromagnetically coupled. Arranged! RU
  • the other end of the antenna sheet 131 located below the through hole 133 is bent forward and disposed on the lower surface of the RFID reader 130. Note that, as described above, since the reader antenna of the RFID reader 130 is located on the lower side, the reader antenna and the other end of the antenna sheet 131 face each other in parallel and are well electromagnetically coupled. .
  • FIG. 1 is a schematic diagram, and thus the force by which the ferrite sheet 135 and the antenna sheet 131 located on the bottom surface of the holding recess 115 of the main body holding member 114 protrude is actually the ferrite sheet 135 and the antenna sheet 131.
  • the thickness of this is negligible and does not obstruct the mounting of the chemical syringe 200 in the holding recess 115.
  • the injection control unit 101 connected to the injection head 110 having the structure as described above by the communication cable 102 has a built-in computer unit 140 as shown in FIG.
  • the imaging control unit 302 is also connected by wire via a communication network 304.
  • the injection control unit 101 includes an operation panel 103, a liquid crystal display 104 as a display device, a speaker unit 105, and the like arranged on the front surface of the main body housing 106, and is a separate controller unit. 107 is wired with connection cable 108.
  • the computer unit 140 is a so-called one-chip microcomputer, which includes a CPU (Central Processing Unit) 141, a ROM (Read Only Memory) 142, and a RAM (Random Access). Memory) 143, l / F (Interface) 144, and the like.
  • CPU Central Processing Unit
  • ROM Read Only Memory
  • RAM Random Access
  • Memory Memory
  • l / F Interface
  • an appropriate computer program is mounted on the information storage medium such as the ROM 142 by using firmware or the like, and the CPU 141 executes various processing operations corresponding to the computer program.
  • the computer unit 140 operates corresponding to the computer program implemented as described above, whereby the operation control means 150 is logically operated as shown in FIG.
  • the operation control means 150 includes a data storage means 151, a data collating means 152, a warning output means 153, a data storage means 154, a data holding means 156, a display control means 157, and an injection control means 158.
  • Etc. have various means logically.
  • the operation control means 150 corresponds to a function in which the CPU 141 executes a predetermined operation corresponding to the computer program installed in the ROM 142 or the like and the recording data wirelessly received from the R FID tag 230.
  • the data storage unit 151 corresponds to a storage area of the RAM 143 that the CPU 141 recognizes data, and stores predetermined confirmation conditions.
  • the data collating means 152 collates the stored confirmation conditions with the record data received wirelessly from the RFID tag 230.
  • the warning output means 153 outputs a confirmation warning corresponding to the collation result.
  • identification data of the usable chemical syringe 200 is registered as a confirmation condition in the RAM 143, and the RFID reader 130 wirelessly receives the recording data from the RFID tag 230 of the chemical syringe 200. Then, the wirelessly received identification data of the chemical syringe 200 is collated with the identification data registered in the RAM 143.
  • the RAM 143 holds the current date and time updated daily as a confirmation condition, and when the expiration date is received wirelessly from the RFID tag 230 of the chemical syringe 200, the expiration date and the current date and time are collated. The If the current date and time exceeds the expiration date, "This product Will expire after the expiration date. Guidance messages such as “Use a new U! Product!” Are displayed on the LCD 104 as a confirmation warning and also output by the speaker unit 105.
  • the serial number of each individual is also recorded in the RFID tag 230, so the data storage means 154 is attached to the injection head 110 and the injection operation is executed.
  • the data collating unit 152 collates the stored manufacturing number with the manufacturing number wirelessly received from the RFID tag 230. If the matched serial numbers match, the warning output means 153 will check the guidance message such as “This prefilled syringe has been used in the past. Please use a new product! And the speaker unit 105 outputs sound.
  • the data holding unit 156 holds the recording data wirelessly received from the RFID tag 230.
  • the display control means 157 displays the stored recording data on the liquid crystal display 104.
  • the injection control means 158 controls the operation of the piston drive mechanism 116 in accordance with the stored recording data.
  • the RFID tag 230 of the chemical syringe 200 includes data such as the name, pressure resistance, and capacity of the chemical syringe 200, and the name, components, and consumption of the chemical solution filled in the chemical syringe 200. Since data such as a time limit is recorded, the recorded data is temporarily stored in the RAM 143 and displayed on the liquid crystal display 104.
  • control data of the piston drive mechanism 116 is recorded in the RFID tag 230 of the chemical syringe 200
  • the control data is stored in the RAM 143.
  • the CPU 141 controls the operation of the piston drive mechanism 116 in accordance with the held control data. For example, if a variable pattern that changes the injection speed of the contrast agent over time is recorded in the RFID tag 230 of the chemical syringe 200, the CPU 141 changes the operating speed of the piston drive mechanism 116 over time corresponding to the variable pattern. Change.
  • the CPU 141 holds the RAM 141 corresponding to the detected pressure of the load cell 118.
  • the operation of the piston drive mechanism 116 is controlled so as not to exceed the set pressure resistance.
  • the CPU 141 controls the operation of the piston drive mechanism 116 in accordance with the volume held in the RAM 143. .
  • Various means of the chemical injection device 100 as described above are powers that are realized by using hardware such as the liquid crystal display 104 as necessary.
  • the main means are resources stored in an information storage medium such as the ROM 142 and the like. This is realized by the function of the CPU 141 which is hardware corresponding to the computer program.
  • Such a computer program is, for example, when the recording data is received wirelessly from the RFID tag 230 by the RFID reader 130, and the confirmation condition stored in the RAM 143 or the like and the recording data received wirelessly from the RFID tag 230.
  • a confirmation warning is output on the display of the liquid crystal display 104, etc.
  • the manufacturing number of the chemical syringe 200 that has been installed and the injection operation has been performed is stored in the RAM 143, etc.
  • the stored serial number and the serial number received wirelessly from the RFID tag 230 are collated, and a confirmation warning is output on the LCD 104 according to the collation result.
  • the recording data received wirelessly from the 230 is stored in the RAM 143 or the like, the stored recording data is displayed on the liquid crystal display 104, and the stored recording data is stored. It is stored in an information storage medium such as the RAM 143 as software for causing the CPU 141 to execute processing operations such as controlling the operation of the piston drive mechanism 116 corresponding to the data.
  • the injection head 110 of the chemical injection device 100 is arranged and used in the vicinity of the imaging unit 301 of the CT scanner 300.
  • a chemical syringe 200 is prepared.
  • the operator opens the movable holding member 123 of the injection head 110 and attaches the drug solution syringe 200 to the holding recess 115 so that the cylinder flange 213 is inserted therein.
  • the operator closes the movable holding member 123.
  • the chemical syringe 200 is affixed to the cylinder body 211, such as a sticker. Since the vertical direction is specified by the operator, when attaching the chemical syringe 200, as shown in FIG. 1 and FIG. 8 (b), the operator must properly place the chemical syringe with the RFID tag 230 positioned below. 200 is attached to the chemical injection device 100.
  • the antenna sheet 131 relays wireless communication between the RFID tag 230 and the RFID reader 130, and the RFID The tag 230 and the RFID reader 130 can communicate wirelessly satisfactorily.
  • step Sl the computer unit 140 determines whether or not the received data matches the confirmation condition registered in the RAM 143 (step S2).
  • the confirmation condition identification data of the usable drug solution syringe 200 is registered. Therefore, if the identification data received wirelessly from the RFID tag 230 is not registered as a confirmation condition, ⁇ This product is not registered as a usable syringe, please confirm that it can be used. '' Are displayed on the liquid crystal display 104 as confirmation warnings and are also output by the speaker unit 105 (step S3).
  • step S3 Guidance messages such as “This syringe has been used in the past. Please use a new product” will be output on the LCD display 104 and the speaker unit 105 as confirmation warnings if the matched serial numbers match. Therefore (step S3), it is possible to easily and reliably prevent medical mistakes and the like in which the chemical syringe 200 that should be discarded after one use is used many times.
  • the RFID tag 230 stores various data to be displayed and various data not to be displayed, for example, whether or not each of the various data is to be displayed. Is set with a binary flag, and the chemical injection device 100 displays an appropriate part of the recording data force received wirelessly from the RFID tag 230.
  • the recording data received wirelessly from the RFID tag 230 of the chemical syringe 200 to the chemical injection device 100 includes "pressure resistance”, “capacity”, and "variable pattern that changes the injection speed of the contrast medium over time”. If the control data is included, the control data is set in the RAM 143 of the converter unit 140 (step S7). If the control data is set in the record data received wirelessly from the RFID tag 230 !, the default control data is set.
  • step S8 transmits the start of work to the CT scanner 300 (step S11).
  • the CT scanner 300 that has received the work start data from the chemical injection device 100 in this way (step T2) returns the work start to the chemical injection device 100 and executes the imaging operation. (Step ⁇ 8). For this reason, in the chemical injection system 1000 of this embodiment, the imaging of the CT scanner 300 follows the chemical injection of the chemical injection device 100.
  • the CT scanner 300 Even when the start of imaging is input (step Tl), the chemical injection of the chemical injection device 100 follows the imaging of the CT scanner 300 (steps T4, T6 ⁇ , S9, S18 ⁇ ). Therefore, in the chemical injection system 1000 of this embodiment, the contrast medium is injected at an accurate timing. A fluoroscopic image can be taken at an appropriate timing.
  • step S18 when a series of operations of chemical injection is performed (from step S18), the injection start force elapsed time is measured (step S18). S19), the operation of the piston drive mechanism 116 is controlled in real time in accordance with the elapsed time and the control data wirelessly received from the RFID tag 230 (step S22).
  • the chemical injection device 100 of the present embodiment for example, when a variable pattern that changes the injection speed of the contrast agent over time is recorded on the RFID tag 230 of the chemical syringe 200, it corresponds to the variable pattern.
  • the operating speed of the piston drive mechanism 116 is changed over time.
  • the piston drive mechanism 116 when the piston drive mechanism 116 is driven as described above, the stress detected by the load cell 118 is received in real time by the computer unit 140 (step S20). Then, the injection pressure of the chemical solution is calculated from the stress detected by the load cell 118 corresponding to the viscosity of the chemical solution wirelessly received from the RFID tag 230 and the inner diameter of the cylinder member 210 (step S21). The operation of the piston drive mechanism 116 is controlled in real time so as to satisfy the pressure range wirelessly received from the tag 230 (step S22).
  • step S23 If the injection pressure becomes an abnormal pressure, a confirmation warning is output and the injection operation is forcibly stopped (step S23), so that it is possible to prevent a medical error in which the drug solution is injected with an abnormal pressure.
  • various data such as the inner diameter of the cylinder member 210 and the viscosity of the chemical solution are required in addition to the stress pressing the piston member 220 of the chemical solution syringe 200. Become. However, such various kinds of data are input to the chemical solution injector 100 by the RFID tag 230. For this reason, the chemical injection device 100 can accurately detect the injection pressure for each chemical solution for each chemical solution syringe 200 without requiring the cumbersome work of manually inputting various data into the chemical solution injection device 100. it can.
  • the RFID tag 230 does not face one end of the antenna sheet 131 in parallel. In this case, since the RFID tag 230 and one end of the antenna sheet 131 are not electromagnetically coupled, the RFID tag 230 and the RFID reader 130 do not communicate wirelessly (step S1).
  • the injection operation is started in a state where the cylinder flange 213 is held by the flat portion 215 by the flange holding member 121, and the cylinder member 211 is destroyed. There is no such thing. Further, even if the chemical syringe 200 is mounted on the injection head 110 with the flat portion 215 of the cylinder flange 213 positioned vertically, the RFID tag 230 and the RFID reader 130 do not communicate wirelessly if the chemical syringe 200 is upside down. (Step SI) The injection operation is not started when the chemical syringe 200 is upside down.
  • step S18 the RFID tag 230 is always detected by the RFID reader 130 (step S18). If the above detection is interrupted before completion of the injection operation (step S32) (step S18), the injection operation by the piston drive mechanism 116 is stopped (step S28).
  • a guidance message such as "Syringe omission detected-Please confirm the syringe installation" is displayed on the LCD 104 as a confirmation warning and voice output is output from the force unit 105.
  • Step S26 abnormal occurrence and injection stop are transmitted to CT scanner 300 (Steps S25, S28).
  • step T10 when the CT scanner 300 receives an error occurrence data (step T10), the error occurrence is output as a confirmation warning on a guidance display or the like (step T16), and when an operation stop is received (step T13). ), The imaging operation is stopped (step ⁇ 18).
  • the chemical solution syringe 200 is appropriately held, and the chemical solution injection can be automatically prevented from being executed in a state, and the chemical solution injection is performed during the chemical solution injection. Even when the syringe 200 has fallen out of its proper position force, the injection of the chemical solution can be automatically stopped.
  • the mechanism for detecting appropriate attachment of the chemical syringe 200 is the RFID tag 230 and the R FID reader 130 for transferring various data from the chemical syringe 200 to the chemical injection device 100 in this manner. Therefore, it is possible to detect the appropriate mounting of the chemical syringe 200 with a simple structure without requiring a dedicated sensor mechanism or the like.
  • the chemical injection device 100 and the CT scanner 300 detect the occurrence of abnormality in the above-mentioned preparation completion state (steps S10 and T3), or detect the occurrence of abnormality during the operation execution. Even so (Step S23, ⁇ 9), the abnormality is output (Step S26, ⁇ 16), and the operation is stopped (Step S28, ⁇ 18).
  • step S25, ⁇ 15 the other side that has received this data (step T10, S24) also outputs the abnormality occurrence (step T16).
  • step S26 the other side that has received the data (steps T13 and S31) executes the operation stop (step S21). T18, S28).
  • step S29, Tl l Even when an operation stop is input to one side (step S29, Tl l), the operation stop is executed (step S28, ⁇ 18) and also sent to the other (step S27). , ⁇ 17) On the other side of receiving the data (steps T13 and S31), the operation is stopped (steps T18 and S28).
  • step S32, T14 When the operation completion is detected on one side (steps S32, T14), the operation end is executed (step S33, ⁇ 19), and the operation end is transmitted to the other side ( In step S34, ⁇ 20), on the other side of receiving the data (step T12, S31), the operation stop is executed (step T18, S28).
  • step S33, S28 when the injection operation ends normally or abnormally as described above (steps S33, S28), the identification data wirelessly received from the RFID tag 230 of the chemical syringe 200 is new. Is registered in the RAM 143 as the confirmation condition (step S36).
  • the chemical injection device 100 of this embodiment is equipped with the RFID reader 130 on the existing injection head 110 with minimal modifications, and this RFID reader 130 is wirelessly communicated with the RFID tag 230 of the chemical syringe 200.
  • the existing antenna sheet 131 can be used.
  • the productivity of the chemical injection device 100 is good. This will be described below.
  • the main body support member 114 that supports the flange holding member 121 is formed of a metal such as an aluminum alloy because sufficient strength is required.
  • a recess is formed in the bottom surface of the holding recess 115 of the main body support member 114, and a reader antenna is provided there. It can be assumed that the RFID reader 130 is arranged so as to be located on the upper surface (not shown).
  • the metal main body support member 114 is positioned in the vicinity of the reader antenna of the RFID reader 130, and the main body support member 114 hinders wireless communication between the RFID reader 130 and the RFID tag 230. Will be.
  • the reader antenna force of the R FID reader 130 is also formed with a large recess so that the main body support member 114 is sufficiently separated, or the main body support member 114 is made of high-strength grease. It can be assumed to form (both not shown). However, this requires a major modification of the existing chemical injection device 100.
  • the RFID reader 130 is arranged on the lower surface of the main body support member 114 with the reader antenna on the lower side, the reader antenna is supported on the main body depending on the thickness of the RFID reader 130.
  • the lower surface force of the member 114 is separated, and the metal main body support member 114 can be prevented from affecting the reader antenna.
  • the RFID reader 130 is positioned below the metal main body support member 114,
  • the RFID tag 230 is disposed on the upper side of the main body support member 114, the RFID tag 230 and the RFI
  • one end of the antenna sheet 131 is arranged at a position facing the RFID tag 230 above the main body support member 114 and the other end is the main body support member 11.
  • RFID reader 13 by attaching it to the reader antenna of RFID reader 130 on the lower side of 4
  • the RFID tag 230 can be electromagnetically coupled well.
  • the antenna sheet 131 is an off-the-shelf product that is mass-produced together with the RFID tag 230, and the modification of the main body support member 114 only forms the slit-shaped through hole 133. Productivity is good.
  • the antenna sheet facing the RFID tag 230 One end force of 131 Since the ferrite sheet 135 is arranged on the surface of the main body support member 114, the electromagnetic field below the antenna sheet 131 passes through the ferrite sheet 135, and the RFID tag 230 and the antenna sheet 131 Electromagnetic coupling with the metal body support member 114 is not hindered.
  • the tag antenna 233 of the RFID tag 230 of the present embodiment is formed as an elongated loop antenna. Therefore, if the tag antenna 233 is bent in the longitudinal direction, the communication performance is extremely lowered. However, in the chemical syringe 200 of this embodiment, since the long direction of the cylinder member 210 and the RFID tag 230 are the same, the tag antenna 233 is simply bent slightly in the short direction, and the longitudinal direction. Is not curved and the communication performance is good.
  • the RFID tag 230 is a force whose communication performance is hindered even by liquid. As described above, the RF ID tag 230 needs to be attached to the cylinder member 210 in a state in which the longitudinal direction coincides with the cylinder member 210. It is difficult to place the RFID tag 230 at a position that is filled with the chemical solution.
  • the drug solution syringe 200 of this embodiment is formed with a sufficient thickness such as the cylinder member 210 force Sl. 5 mm to 2.0 mm, the RFID tag 230 attached to the surface of the syringe 200 is a cylinder. Wireless communication can be satisfactorily performed without being hindered by the chemical solution filled in the part 210.
  • the present invention is not limited to the above embodiment, and various modifications are allowed without departing from the spirit of the present invention.
  • the chemical injection device 100 in which only one chemical syringe 200 is attached to the injection head 110 is illustrated, but as shown in FIG. 13, the chemical solution in which a plurality of chemical syringes 200 are attached to the injection head 170
  • An injection device (not shown) can also be implemented.
  • the recording data detected by the RFID reader 130 from the RFID tag 230 is displayed on the liquid crystal display 104 of the injection control unit 101 separate from the injection head 110. did. However, as shown in FIG. 13, it is possible to mount a display device 171 such as a liquid crystal display on the injection head 170 and display the recorded data of the RFID tag 230 there. [0118] In this case, when the chemical syringe 200 is properly attached to the injection head 170, the recorded data is displayed on the display device 171 of the injection head 170, so that the operator can properly use the chemical syringe 200. It is possible to quickly check whether it is installed and to recognize the display data intuitively.
  • a force exemplifying that the fixed holding member 122 of the pair of left and right flange holding members 121 is separated into the left and right together with the movable holding member 123 For example, the left and right fixed holding members are integrally formed below. It is also possible that only the movable holding member 123 is separated to the left and right (not shown). Alternatively, as shown in FIG. 13, it is possible that the flange holding member is formed integrally with the main body holding member 174 only by the fixed holding member 173 that does not move.
  • a convex portion is formed on at least one of the front surface and the rear surface of the holding slit of the fixed holding member, and the convex portion is formed on a concave portion formed only on at least one lower portion of the front surface and the rear surface of the cylinder flange. It is also possible to engage (not shown). In this case, even when the flat portion of the cylinder flange is positioned up and down, the chemical syringe is not attached to the chemical injection device in the opposite state.
  • the upward force is also visually recognized through the cylinder member 210 filled with a transparent chemical solution.
  • the symbol having a predetermined shape is divided into the lower surface of the cylinder member 210 and the inner surface of the holding recess 115 of the main body holding member 114 (not shown). In this case, whether or not the chemical syringe is properly held can be confirmed by both the RFID reader 130 and the above-described design, and the force with which the cylinder member 210 is filled with the chemical solution can also be confirmed by the design. it can.
  • the RFID tag 230 is mounted on the cylinder member 210 in a state in which the longitudinal direction coincides.
  • the RFI D tag 230 can be mounted on the outer peripheral surface of the cylinder member 210 so as to be wound in the longitudinal direction! (Not shown)
  • the force exemplifying that the entire cylinder member 210 is formed with a thickness that does not inhibit the electromagnetic induction of the RFID tag 230.
  • the thickness of the cylinder member If this is not sufficient, it is possible to form only the part where the RFID tag 230 is attached to a predetermined thickness, and attach the RFID tag 230 to the cylinder member via a pedestal of grease, etc. Is possible (both not shown).
  • a ferromagnetic material such as ferrite having a high magnetic permeability is formed in a sheet shape having the same shape as that of the RFID tag 230, and the RFID tag 230 is disposed on the outer peripheral surface of the cylinder member 210 via the magnetic material. Is also possible (not shown). In this case, since the electromagnetic field on the back side of the RFID tag 230 passes through the magnetic material, the electromagnetic field can be prevented from being absorbed by the chemical solution, and the communication performance of the RFID tag 230 can be improved.
  • the upper part which is one end of the antenna sheet 131 inserted through the through hole 133 of the main body support member 114, is bent rearward and disposed at a position facing the RFID tag 230.
  • the lower end which is the other end, is bent forward and is shown in close contact with the RFID reader 130.
  • the RFID reader 130 is disposed behind the through-hole 133, and the lower portion of the antenna sheet 131 can be bent rearward to be in close contact with the RFID reader 130. It is also possible that the upper part of the PC is bent forward so as to face the RFID tag 230 (both not shown).
  • the through hole 133 is formed in the lower part of the main body holding member 114 of the chemical liquid injector 100, and the antenna sheet 131 and the RFID reader 130 are arranged.
  • the RFID tag 230 is placed at the bottom.
  • through holes 133 are formed in the left and right parts of the main body holding member 114 and the antenna sheet 131 and the RFID reader 130 are arranged, and the corresponding left part of the cylinder member 210 is arranged. It is also possible that the RFID tag 230 is arranged on the right side or the like (not shown).
  • the ferrite sheet 135 and the antenna sheet 131 having negligible thicknesses are arranged on the bottom surface of the holding recess 115 of the main body holding member 114, but for example, the holding recess 115 One end of the ferrite sheet 135 and the antenna sheet 131 can also be disposed by forming a concave hole in the bottom surface (not shown). In this case, ferrite Even when the thickness of the sheet 135 and the antenna sheet 131 cannot be ignored, the chemical syringe 200 can be satisfactorily attached to the holding recess 115 without being obstructed by the thickness.
  • the upper surface of the other end of the antenna sheet 131 is illustrated as being closely attached to the lower surface of the RFID reader 130.
  • the antenna sheet 131 It is also possible for the upper surface of the end and the lower surface of the RFID reader 130 to face each other apart (not shown).
  • the size of the chemical syringe 200 attached to the chemical injection device 100 is one.
  • the chemical syringe 200 has a plurality of sizes, and as shown in FIG. 14, a cylinder adapter 400 is prepared for each chemical syringe 200 of a size other than the maximum. Yes.
  • the chemical solution syringe 200 having the maximum size is directly attached to the chemical solution injection device 100, and the chemical solution syringe 200 having a size other than the maximum size is attached via the cylinder adapter 400. Therefore, when the cylinder adapter 400 is properly attached to the chemical injection device 100, the RFID tag 230 may be attached to the outer surface or inner surface of the cylinder adapter 400 that faces the one end of the antenna sheet 131 in parallel. Is possible.
  • the chemical liquid injector 100 can check whether both the cylinder adapter 400 and the chemical syringe 200 are properly attached. Then, by comparing the recorded data of the cylinder adapter 400 with the recorded data of the chemical syringe 200, it can be confirmed that the combination of the chemical syringe 200 and the cylinder adapter 400 is appropriate.
  • the chemical injection device 100 can use both the cylinder adapter 400 and the chemical syringe 200 with one RFID reader 130. Wireless communication with RFID tag 230.
  • the RFID tag 230 of the chemical solution syringe 200 and the antenna sheet 131 of the chemical solution injection device 100 face each other via the cylinder adapter 400. Radio between RFID tag 230 and RFID reader 130 It is preferable to form with a non-magnetic material such as rosin that does not hinder communication.
  • the chemical injection device 100 wirelessly receives the manufacturing number for each individual from the RFID tag 230 of the chemical syringe 200 used by the RFID reader 130.
  • This example illustrates that a confirmation warning is output when a new serially received serial number is stored.
  • the RFID tag 230 of the chemical syringe 200 is set as a product in which data can be added, and the chemical injection device 100 records the used state in the RFID tag 230 of the chemical syringe 200 that is installed and the injection operation is executed. It is also possible to output a confirmation warning when used is received wirelessly from the RFID tag 230 of the new chemical syringe 200.
  • chemical solution injection control data and the like are also received wirelessly from the RFID tag 230 of the chemical syringe 200 to the chemical injection device 100, and the chemical injection device 100 controls the chemical injection operation according to the control data.
  • the chemical injection device 100 may control the chemical injection operation corresponding to a combination of control data received wirelessly from the RFID tag 230 of the chemical syringe 200 and control data input from the operation panel 103 or the like. Is possible.
  • a time-varying pattern of chemical injection is recorded in the RFID tag 230 of the chemical syringe 200, and when an imaging region by the CT scanner 300 is input to the operation panel 103 or the like, It is also possible to adjust the variable pattern corresponding to the imaging region.
  • the chemical injection device 100 that has registered the serial number received wirelessly from the RFID tag 230 of the chemical syringe 200 after completing the injection operation ends various operations.
  • the chemical injection device 100 that has completed the injection operation and registration of the serial number data as described above detects the removal of the chemical syringe 200 by the RFID reader 130, the piston drive mechanism 116 is moved to the initial position at the end. Can be automatically retracted Noh.
  • the piston drive mechanism 116 is automatically arranged at an appropriate position by attaching / detaching the chemical syringe 200 to / from the chemical injection device 100 at an appropriate timing.
  • the convenience of the chemical injection device 100 can be further improved.
  • the force that the manufacturer assumes to record various data in the RFID tag 230 of the chemical syringe 200 is used in a medical site such as a hospital where the chemical syringe 200 is used.
  • Various data can be recorded on the RFID tag 230.
  • the piston member 220 is pushed into the cylinder member 210 of the drug solution syringe 200 in order for the drug solution injection device 100 to inject the drug solution into the subject.
  • a separate drug solution pack is extended.
  • the chemical solution injection device 100 can also fill the chemical solution syringe 200 with the chemical solution (not shown).
  • the CT scanner 300 is used as the fluoroscopic imaging apparatus, and the chemical injection device 100 injects the contrast medium for CT.
  • the MRI apparatus and the PET apparatus are used as the fluoroscopic imaging apparatus. It is also possible to inject a contrast medium for the same using a chemical injection device.
  • each part such as the chemical liquid injector 100 has been specifically described.
  • the drive source of the piston drive mechanism is formed by a direct current (DC) motor, ultrasonic motor, linear motor or solenoid! -Luminescence) It can also be formed with a display or plasma display (not shown).
  • the CPU 141 is operated corresponding to the computer program stored in the RAM 143 and the like, and various means are logically realized as various functions of the chemical solution injector 100.
  • each of these various means can be formed as unique hardware, and a part can be stored in the RAM 143 as software and a part can be formed as node hardware.

Abstract

An RFID tag (230) is attached to a cylinder body (211) of a medicinal-liquid syringe (200). A medicinal-liquid injection device (100) has a body holding member (114) made of metal and holding the cylinder body (211) on its upper surface. An RFID reader (130) is placed on the lower surface of the body holding member (114). A holding recess (115) for holding the cylinder body (211) is provided in the body holding member (114), and a through-hole is formed in the holding recess (115). An antenna sheet (131) is inserted in the through-hole. One end of the antenna sheet (131) is placed on the inner surface of the holding recess (115) and the other end is faced to the RFID reader (130).

Description

明 細 書  Specification
薬液注入システム  Chemical injection system
技術分野  Technical field
[0001] 本発明は、薬液シリンジの薬液を薬液注入装置で被験者に注入する薬液注入シス テムに関し、特に、 CT(Computed  TECHNICAL FIELD [0001] The present invention relates to a chemical solution injection system for injecting a chemical solution of a chemical solution syringe into a subject with a chemical solution injection device.
Tomography)スキャナなどの透視撮像装置で透視画像が撮像される被験者に造影剤 を注入する薬液注入システムに関する。  Tomography) The present invention relates to a chemical injection system that injects a contrast medium into a subject whose fluoroscopic image is captured by a fluoroscopic imaging device such as a scanner.
背景技術  Background art
[0002] 現在、被験者の透視画像を撮像する透視撮像装置としては、 CTスキャナ、 MRI(M agnetic Resonance Imaging)装 、 PET(Positron Emission Tomography)装 、超音 波診断装置、 CTアンギオ装置、 MRA(MR  [0002] Currently, as a fluoroscopic imaging device for imaging a fluoroscopic image of a subject, a CT scanner, an MRI (Magnetic Resonance Imaging) device, a PET (Positron Emission Tomography) device, an ultrasonic diagnostic device, a CT angiography device, an MRA (MRA) MR
Angio)装置、等がある。上述のような透視撮像装置を使用するとき、被験者に造影剤 や生理食塩水などの薬液を注入することがあり、この注入を自動的に実行する薬液 注入装置も実用化されて!/、る。  Angio) equipment, etc. When using a fluoroscopic imaging device as described above, a chemical solution such as a contrast medium or physiological saline may be injected into the subject, and a chemical injection device that automatically performs this injection has also been put into practical use! .
[0003] このような薬液注入装置は、例えば、駆動モータゃスライダ機構などを有するピスト ン駆動機構を有しており、薬液シリンジが着脱自在に装着される。その薬液シリンジ は、一般的にシリンダ部材とピストン部材とを有しており、シリンダ部材にピストン部材 がスライド自在に挿入されて!、る。  [0003] Such a chemical solution injection device has, for example, a piston drive mechanism including a drive motor and a slider mechanism, and a chemical solution syringe is detachably attached thereto. The chemical syringe generally has a cylinder member and a piston member, and the piston member is slidably inserted into the cylinder member.
[0004] より詳細には、シリンダ部材は円筒状のシリンダ本体を有しており、その閉塞された 前端中央に導管部が形成されている。シリンダ本体の後端は開口されており、その開 口部から内部にピストン部材が挿入されて 、る。またシリンダ本体の後端外周には円 環状のシリンダフランジが形成されて 、る。  More specifically, the cylinder member has a cylindrical cylinder body, and a conduit portion is formed at the center of the closed front end. The rear end of the cylinder body is opened, and a piston member is inserted into the inside through the opening. An annular cylinder flange is formed on the outer periphery of the rear end of the cylinder body.
[0005] このような薬液シリンジには、プレフィルドタイプと後充填タイプがある。プレフィルド タイプは、シリンダ部材に薬液が充填されて全体が梱包材で密封された状態で出荷 される。後充填タイプは、利用者により所望の薬液がシリンダ部材に充填される。なお 、以下では説明を簡単にするため、薬液シリンジがプレフィルドタイプであることを前 提として説明する。 [0006] 上述のような薬液シリンジの薬液を被験者に注入する場合、作業者は適切な薬液 の薬液シリンジを用意し、梱包材カも薬液シリンジを取り出す。その薬液シリンジを延 長チューブで被験者に連結して薬液注入装置に装着すると、フランジ保持部材によ りシリンダフランジが保持される。このような状態で、薬液注入装置は、所定操作に対 応してピストン駆動機構でピストン部材をシリンダ部材に圧入させる。これにより、で薬 液シリンジ力 被験者に薬液が注入されることになる。 [0005] Such a liquid syringe includes a prefilled type and a post-filling type. The pre-filled type is shipped with the cylinder member filled with chemicals and sealed entirely with packing material. In the post-filling type, a cylinder member is filled with a desired chemical solution by a user. In the following, in order to simplify the description, it is assumed that the chemical syringe is a prefilled type. [0006] When injecting a chemical solution of the above-described chemical solution syringe into a subject, an operator prepares a chemical solution syringe of an appropriate chemical solution, and takes out the chemical solution syringe from the packing material. When the chemical syringe is connected to the subject with an extension tube and attached to the chemical injection device, the cylinder flange is held by the flange holding member. In such a state, the chemical injection device press-fits the piston member into the cylinder member by the piston drive mechanism in response to a predetermined operation. As a result, the drug solution is injected into the subject by the drug syringe force.
[0007] その場合、作業者が薬液の種類などを考慮して注入速度や注入総量などを決定し 、それを薬液注入装置に入力すると、この薬液注入装置は入力データに対応して薬 液を被験者に注入する。例えば、薬液として造影剤を注入すれば被験者の造影度が 変化するので、透視撮像装置により良好な透視画像が撮像されることになる。  [0007] In that case, when the operator determines the injection speed, the total injection amount, etc. in consideration of the type of the chemical solution and inputs it to the chemical solution injection device, the chemical solution injection device supplies the chemical solution corresponding to the input data. Inject the subject. For example, if a contrast medium is injected as a chemical solution, the contrast level of the subject changes, and a good fluoroscopic image is captured by the fluoroscopic imaging device.
[0008] なお、薬液注入装置には造影剤とともに生理食塩水も被験者に注入できる製品が ある。その場合、作業者は所望により造影剤の注入完了に連動して生理食塩水を注 入することを注入速度や注入総量などとともに薬液注入装置に入力する。すると、薬 液注入装置は、被験者に入力データに対応して造影剤を注入してから、自動的に生 理食塩水も注入する。このため、造影剤を生理食塩水で後押しして造影剤の消費量 を削減することや、生理食塩水によりアーチファクトを軽減することができる。  [0008] It should be noted that there are products that can inject physiological saline as well as a contrast medium into a subject. In that case, the operator inputs the injection of the physiological saline in conjunction with the completion of the injection of the contrast agent as desired, together with the injection speed, the total injection amount, and the like to the drug solution injector. Then, the chemical injection device automatically injects physiological saline after injecting a contrast medium into the subject according to the input data. For this reason, the contrast medium can be boosted with physiological saline to reduce the consumption of the contrast medium, and the artifact can be reduced with the physiological saline.
[0009] なお、造影剤は高粘度である力 薬液注入装置は、薬液シリンジのシリンダ部材に ピストン部材を高圧で押し込むことができるので、造影剤の注入には好適である。た だし、ピストン部材をシリンダ部材に高圧で押し込むためには、そのシリンダ部材を強 固に保持することも必要となる。  [0009] It is to be noted that a force chemical liquid injection device having a high viscosity contrast medium is suitable for injecting a contrast medium because a piston member can be pushed into a cylinder member of a chemical liquid syringe at a high pressure. However, in order to push the piston member into the cylinder member at a high pressure, it is necessary to hold the cylinder member firmly.
[0010] このため、本出願人が実施している薬液注入装置では、左右一対の金属製のフラ ンジ保持部材を有しており、そのフランジ保持部材を金属製の本体保持部材で開閉 自在に支持している。この本体保持部材は上面に保持凹部が形成されており、その 保持凹部で上方カゝら挿入されるシリンダ本体を保持する。左右一対のフランジ保持 部材は、相対する内面に保持スリットが形成されており、開放状態で上方から挿入さ れる薬液シリンジのシリンダフランジの左部と右部とを、閉止状態で保持する。  [0010] For this reason, the chemical injection device implemented by the present applicant has a pair of left and right metal flange holding members, and the flange holding member can be freely opened and closed by the metal main body holding member. I support it. The main body holding member has a holding recess formed on the upper surface, and holds the cylinder main body inserted from the upper side by the holding recess. The pair of left and right flange holding members are formed with holding slits on the inner surfaces facing each other, and hold the left and right portions of the cylinder flange of the chemical syringe inserted from above in an open state in a closed state.
[0011] なお、このように開閉自在な一対のフランジ保持部材でシリンダフランジを保持する 薬液注入装置は、本出願人により各種の構造で出願されている (例えば、特許文献 1 〜5参照)。 [0011] It should be noted that such a chemical injection device that holds the cylinder flange with a pair of openable and closable flange holding members has been filed with various structures by the present applicant (for example, Patent Document 1). See ~ 5).
特許文献 1 :特開 2004— 154238号  Patent Document 1: Japanese Patent Application Laid-Open No. 2004-154238
特許文献 2:特開 2004— 154239号  Patent Document 2: JP 2004-154239 A
特許文献 3 :特開 2004— 187849号  Patent Document 3: JP 2004-187849
特許文献 4:特開 2004 - 243009号  Patent Document 4: Japanese Patent Application Laid-Open No. 2004-243009
特許文献 5:特開 2004 - 290454号  Patent Document 5: Japanese Patent Application Laid-Open No. 2004-290454
上述のような薬液注入装置では、金属製のフランジ保持部材により薬液シリンジの シリンダフランジを強固に保持することができるので、薬液シリンジのシリンダ部材に ピストン部材を高圧で押し込んで高粘度な造影剤などを被験者に良好に注入するこ とが可能である。しかも、開閉自在なフランジ保持部材を金属製の本体保持部材で 支持しているので、薬液シリンジ力 フランジ保持部材に多大な応力が作用しても、 例えば、本体保持部材が変形したり破損したりすることもな 、。  In the chemical injection device as described above, the cylinder flange of the chemical syringe can be firmly held by the metal flange holding member. Therefore, a high viscosity contrast agent is formed by pushing the piston member into the cylinder member of the chemical syringe at a high pressure. Can be successfully injected into a subject. Moreover, since the flange holding member that can be opened and closed is supported by the metal main body holding member, even if a large amount of stress acts on the chemical liquid syringe force flange holding member, for example, the main body holding member may be deformed or damaged. Don't do it.
[0012] ただし、現在の一般的な薬液シリンジは、無用な転がりなどを防止するため、シリン ダフランジの外周面の一部に平坦部が形成されている。この平坦部は、通常はシリン ダフランジの円形の外周面を部分的に直線状に切除した形状に形成されており、シ リンダフランジの外周面の相対する位置に対となるように平行に形成されている。そこ で、前述の薬液注入装置は、シリンダフランジの平坦部ではない円形部をフランジ保 持部材で保持するように構成されている。そのため、作業者は、シリンダフランジを円 形部の位置でフランジ保持部材に保持させる必要がある。  [0012] However, in the current general drug solution syringe, a flat portion is formed on a part of the outer peripheral surface of the cylinder flange in order to prevent unnecessary rolling and the like. The flat portion is usually formed in a shape obtained by partially cutting the circular outer peripheral surface of the cylinder flange in a straight line, and is formed in parallel so as to be paired with the opposite position of the outer peripheral surface of the cylinder flange. ing. Therefore, the above-described chemical injection device is configured to hold a circular portion, which is not a flat portion of the cylinder flange, with a flange holding member. Therefore, the operator needs to hold the cylinder flange on the flange holding member at the position of the circular portion.
[0013] しかし、フランジ保持部材がシリンダフランジを平坦部の位置で保持した状態でも、 外観上は薬液シリンジが薬液注入装置に適切に保持されているように見える。この場 合、フランジ保持部材がシリンダフランジを保持する面積が減少するため、ピストン部 材がシリンダ部材に高圧で押し込まれるとシリンダフランジを破損する可能性がある。  [0013] However, even when the flange holding member holds the cylinder flange at the position of the flat portion, it appears that the chemical syringe is appropriately held by the chemical injection device. In this case, since the area where the flange holding member holds the cylinder flange decreases, the cylinder flange may be damaged if the piston member is pushed into the cylinder member at a high pressure.
[0014] さらに、現在ではシリンダフランジの一対の平坦部のうち一方が上方を向くように規 定されている薬液シリンジもあるので、この場合はシリンダフランジが円形部でフラン ジ保持部材に保持されても、薬液シリンジの上下方向が逆様となっていると不具合が 発生する。  [0014] Furthermore, some chemical syringes are currently specified so that one of the pair of flat portions of the cylinder flange faces upward. In this case, the cylinder flange is held by the flange holding member at the circular portion. However, if the vertical direction of the chemical syringe is reversed, a problem occurs.
[0015] 例えば、本出願人力特願 2004— 110853号 (WO2005Z097232A1)として出 願した薬液注入システムでは、透明な薬液が充填されて ヽるシリンダ部材を介して上 方から視認されると所定の形状となる図柄が、シリンダ部材の下面と本体保持部材の 保持凹部の内面とに分割されて表記されている。 [0015] For example, the present applicant's power application 2004-110853 (WO2005Z097232A1) In the chemical solution injection system that has been requested, a pattern that has a predetermined shape when viewed from above through a cylinder member filled with a transparent chemical solution is formed on the lower surface of the cylinder member and the inner surface of the holding recess of the main body holding member. It is divided into two.
[0016] この薬液注入システムでは、薬液が充填されている薬液シリンジが薬液注入装置に 適切に装着された場合のみ、図柄が所定の形状としてシリンダ部材の上方力 視認 される。この視認により、薬液シリンジが適切に保持されていることと、シリンダ部材に 薬液が充填されていることと、の両方を一度に確認することができる。  [0016] In this chemical solution injection system, the upward force of the cylinder member is visually recognized as a predetermined shape only when the chemical solution syringe filled with the chemical solution is properly attached to the chemical solution injection device. By this visual recognition, it is possible to confirm both that the chemical syringe is appropriately held and that the cylinder member is filled with the chemical solution at a time.
[0017] しかし、このような薬液注入システムでは、シリンダフランジが円形部でフランジ保持 部材に保持されても、薬液シリンジの上下方向が逆様となっていると、薬液シリンジが 適切に保持されていること、およびシリンダ部材に薬液が充填されていることのどちら も確認することができない。  [0017] However, in such a chemical solution injection system, even if the cylinder flange is held by the flange holding member at the circular portion, the chemical solution syringe is appropriately held when the vertical direction of the chemical solution syringe is reversed. Neither it is confirmed that the cylinder member is filled with the chemical solution.
[0018] さら〖こ、上述のような薬液注入装置では、薬液シリンジから被験者に薬液を注入す るが、適正な薬液を注入するためには作業者が適切な薬液シリンジを選択する必要 力 Sある。しかし、薬液シリンジは薬液の種類が相違しても外観が同一や類似の製品が あるため、作業者が適切でな 、薬液の薬液シリンジを薬液注入装置に装着する可能 '性がある。  [0018] In the chemical injection device as described above, the chemical solution is injected into the subject from the chemical solution syringe. In order to inject the appropriate chemical solution, the operator needs to select an appropriate chemical solution syringe. is there. However, since there are products with the same or similar appearance even if the type of the chemical solution is different, there is a possibility that the operator may attach the chemical syringe of the chemical solution to the chemical injection device.
[0019] また、薬液シリンジとして適合品ではない製品が使用されることもあり、その耐圧な どの性能が適切でないために医療事故が発生することもある。さらに、プレフィルドタ イブの薬液シリンジは、感染などを防止するために一度の使用で廃棄されるが、現在 の薬液注入装置では、一度使用された薬液シリンジが再度使用されることを防止で きない。  [0019] In addition, a product that is not a compatible product may be used as a chemical syringe, and a medical accident may occur due to inadequate performance such as pressure resistance. In addition, prefilled type drug syringes are discarded after a single use in order to prevent infection, but current drug injectors cannot prevent a drug syringe once used from being used again. .
[0020] さらに、前述のように薬液注入装置には使用する薬液や薬液シリンジに対応して注 入速度や注入総量などを入力する必要がある。しかし、この作業は煩雑で熟達して V、な 、作業者には困難であり、適切でな!、数値が入力操作されることを防止できな い。特に、現在の造影剤には有効成分の濃度が数倍まで相違する製品があるので、 それを考慮しないと適量の数倍や数分の一の造影剤が注入されることになる。  [0020] Further, as described above, it is necessary to input the injection speed, the total injection amount, and the like corresponding to the chemical solution to be used and the chemical solution syringe. However, this operation is complicated and proficient, and it is difficult for the operator, and it is not appropriate to prevent the input operation of numerical values. In particular, there are products in which the concentration of the active ingredient differs by several times in current contrast agents. If this is not taken into account, several times or a fraction of the appropriate amount of contrast agent will be injected.
[0021] 同様に、被験者の撮像部位や体重などによっても、薬液の注入速度などの薬液注 入装置へのデータ入力が必要な場合があり、このような作業も煩雑で入力ミスを防止 することができない。特に、本出願人は造影剤の注入速度を変化させることで造影効 果を向上できることを出願したが (特開 2004— 113475号公報)、このような可変パタ ーンを薬液注入装置に入力することは容易ではない。 [0021] Similarly, depending on the imaging region and body weight of the subject, it may be necessary to input data to the chemical injection device, such as the injection rate of the chemical, which is complicated and prevents input errors. Can not do it. In particular, the applicant has filed that the contrast effect can be improved by changing the injection speed of the contrast medium (Japanese Patent Laid-Open No. 2004-113475), and such a variable pattern is input to the chemical liquid injector. It is not easy.
発明の開示  Disclosure of the invention
[0022] 本発明は上述のような課題に鑑みてなされたものであり、フランジ保持部材が薬液 シリンジを適切に保持して 、な 、状態でピストン駆動機構が駆動されることを自動的 に防止できる薬液注入システムを提供することを目的とする。  The present invention has been made in view of the above-described problems, and the flange holding member appropriately holds the chemical syringe, and automatically prevents the piston drive mechanism from being driven in this state. An object of the present invention is to provide a chemical solution injection system that can be used.
[0023] 本発明の薬液注入システムは、薬液シリンジと薬液注入装置とを有して!/、る。薬液 シリンジは、シリンダ本体の後端外周にシリンダフランジが形成されて ヽるシリンダ部 材と、シリンダ部材にその後方力 スライド自在に挿入されているピストン部材とを有 する。薬液注入装置は、薬液シリンジのシリンダ部材にピストン部材を押し込んで薬 液を被験者に注入する。  [0023] The chemical solution injection system of the present invention includes a chemical solution syringe and a chemical solution injection device. The chemical syringe includes a cylinder member having a cylinder flange formed on the outer periphery of the rear end of the cylinder body, and a piston member that is slidably inserted into the cylinder member in a backward direction. The chemical injection device pushes the piston member into the cylinder member of the chemical syringe and injects the chemical into the subject.
[0024] 薬液シリンジは、シリンダ本体の外周面上に RFIDタグが装着されて!、る。 RFIDタ グは、回路チップと、回路チップに結線された平面形状のループアンテナとを有して おり、電磁誘導により記録データを無線送信する。  [0024] The chemical syringe has an RFID tag mounted on the outer peripheral surface of the cylinder body. The RFID tag has a circuit chip and a planar loop antenna connected to the circuit chip, and wirelessly transmits recording data by electromagnetic induction.
[0025] 薬液注入装置は、本体保持部材、フランジ保持部材、ピストン駆動機構、 RFIDリ ーダ、動作制御手段、およびアンテナシートを有している。本体保持部材は、金属製 で、上方から挿入されるシリンダ本体を保持凹部で保持する。フランジ保持部材は、 金属製で本体保持部材に支持されており、上方カゝら挿入されるシリンダフランジを保 持する。ピストン駆動機構は、シリンダフランジとともに保持されたシリンダ部材にビス トン部材を押し込む。 RFIDリーダは、 RFIDタグの記録データを電磁誘導により無線 受信する。動作制御手段は、記録データの無線受信に対応してピストン駆動機構の 動作を制御する。アンテナシートは、細長形状のループアンテナを有している。  [0025] The chemical liquid injector includes a main body holding member, a flange holding member, a piston drive mechanism, an RFID reader, an operation control means, and an antenna sheet. The main body holding member is made of metal, and holds the cylinder main body inserted from above by the holding recess. The flange holding member is made of metal and supported by the main body holding member, and holds the cylinder flange inserted from the upper side. The piston drive mechanism pushes the piston member into the cylinder member held together with the cylinder flange. The RFID reader wirelessly receives the RFID tag recording data by electromagnetic induction. The operation control means controls the operation of the piston drive mechanism in response to the wireless reception of the recording data. The antenna sheet has an elongated loop antenna.
[0026] そして、本体保持部材には、保持凹部の外面から内面まで貫通孔が形成されてい る。 RFIDリーダは、保持凹部の外面の、貫通孔に隣接した位置に配置されている。 保持凹部の貫通孔に揷通されているアンテナシートの一端が保持凹部の内面に配 置され、かつ他端が RFIDリーダに対向している。それにより、例えば、薬液注入装置 に薬液シリンジが適切に装着されることで RFIDタグがアンテナシートの一端に平行 に対向するようにできる。 [0026] A through hole is formed in the main body holding member from the outer surface to the inner surface of the holding recess. The RFID reader is arranged at a position adjacent to the through hole on the outer surface of the holding recess. One end of the antenna sheet passed through the through hole of the holding recess is disposed on the inner surface of the holding recess, and the other end faces the RFID reader. Thus, for example, the RFID tag is parallel to one end of the antenna sheet by properly attaching the chemical syringe to the chemical injection device. It can be made to face.
[0027] なお、上述のような RFIDタグとアンテナシートは、例えば、略長方形のシート状に 形成されていることが可能である。そのアンテナシートは、回路チップが省略された R FIDタグに相当する構造として形成されていることが可能である。このような RFIDタ グおよびアンテナシートは、統一規格の通信デバイスとして認可され、既製品として 量産されている。 [0027] The RFID tag and the antenna sheet as described above can be formed in a substantially rectangular sheet shape, for example. The antenna sheet can be formed as a structure corresponding to an R FID tag in which the circuit chip is omitted. Such RFID tags and antenna sheets are approved as communication devices of the unified standard and are mass-produced as off-the-shelf products.
[0028] 本発明の薬液注入システムでは、例えば、薬液注入装置に薬液シリンジが適切に 装着されることで RFIDタグがアンテナシートの一端に平行に対向するようにできるの で、 RFIDタグとともに量産されている既存のアンテナシートを利用して、薬液注入装 置に薬液シリンジが適切に装着されているかを簡単かつ確実に検出することができる  [0028] In the chemical injection system of the present invention, for example, the RFID tag can be made to face the one end of the antenna sheet in parallel by appropriately attaching the chemical syringe to the chemical injection device. It is possible to easily and reliably detect whether a chemical syringe is properly attached to the chemical injection device using the existing antenna sheet.
[0029] 本発明で云う各種手段は、その機能を実現するように形成されていれば良ぐ例え ば、所定の機能を発揮する専用のハードウェア、所定の機能がコンピュータプロダラ ムにより付与されたデータ処理装置、コンピュータプログラムによりデータ処理装置に 実現された所定の機能、これらの組み合わせ、等として実現することができる。 The various means referred to in the present invention are preferably provided so as to realize their functions. For example, dedicated hardware that exhibits a predetermined function and a predetermined function are given by a computer program. The data processing device, a predetermined function implemented in the data processing device by a computer program, a combination thereof, and the like can be realized.
[0030] また、本発明で云う各種の構成要素は、個々に独立した存在である必要もなぐ複 数の構成要素が 1個の部材として形成されていること、 1つの構成要素が複数の部材 で形成されていること、ある構成要素が他の構成要素の一部であること、ある構成要 素の一部と他の構成要素の一部とが重複して 、ること、等も可能である。  [0030] Further, in the various constituent elements referred to in the present invention, a plurality of constituent elements that do not need to be independent from each other are formed as one member, and one constituent element includes a plurality of members. It is possible that a component is a part of another component, a part of a component overlaps a part of another component, etc. is there.
[0031] さらに、本発明では前後や上下の方向を規定しているが、これは本発明の構成要 素の相対関係を簡単に説明するために便宜的に規定したものであり、本発明を実施 する場合の製造時や使用時の方向を限定するものではない。また、本発明で云うァ ンテナシートの、一端、他端、左端、右端、とは、その長手方向の最外縁部から任意 の範囲までの部分を意味しており、例えば、略正方形の部分などで良い。  [0031] Furthermore, in the present invention, the front-rear direction and the up-down direction are defined, but this is defined for convenience in order to briefly explain the relative relationship of the constituent elements of the present invention. It does not limit the direction of production or use when it is implemented. Further, the one end, the other end, the left end, and the right end of the antenna sheet referred to in the present invention mean a portion from the outermost edge in the longitudinal direction to an arbitrary range, such as a substantially square portion. Good.
図面の簡単な説明  Brief Description of Drawings
[0032] [図 1]本発明の一実施形態による薬液注入装置の注入ヘッドに薬液シリンジが装着さ れる状態を示す要部の模式的な縦断側面図である。  FIG. 1 is a schematic longitudinal side view of a main part showing a state in which a chemical syringe is attached to an injection head of a chemical injection device according to an embodiment of the present invention.
[図 2]注入ヘッドに薬液シリンジが装着される状態を示す斜視図である。 圆 3]薬液注入装置の外観を示す斜視図である。 FIG. 2 is a perspective view showing a state in which a chemical syringe is attached to an injection head. 圆 3] It is a perspective view showing the appearance of the chemical liquid injector.
圆 4]透視撮像装置である CTスキャナの外観を示す斜視図である。 4] A perspective view showing the appearance of a CT scanner that is a fluoroscopic imaging device.
[図 5]薬液注入システムの回路構造を示すブロック図である。  FIG. 5 is a block diagram showing a circuit structure of the chemical solution injection system.
圆 6]薬液シリンジの外観を示す斜視図である。 [6] FIG. 6 is a perspective view showing an appearance of a chemical syringe.
圆 7]RFIDタグの外観を示す模式的な斜視図である。 [7] FIG. 7 is a schematic perspective view showing the appearance of the RFID tag.
圆 8]注入ヘッドに薬液シリンジが装着された状態を示す要部の模式的な正面図であ る。 [8] FIG. 8 is a schematic front view of the main part showing a state in which the chemical syringe is attached to the injection head.
圆 9]薬液注入装置の論理構造を示すブロック図である。 [9] FIG. 9 is a block diagram showing a logical structure of the chemical liquid injector.
[図 10]薬液注入装置の処理動作の前半部分を示すフローチャートである。 FIG. 10 is a flowchart showing the first half of the processing operation of the chemical liquid injector.
[図 11]薬液注入装置の処理動作の後半部分を示すフローチャートである。 FIG. 11 is a flowchart showing the latter half of the processing operation of the chemical injection device.
[図 12]CTスキャナの処理動作を示すフローチャートである。 FIG. 12 is a flowchart showing the processing operation of the CT scanner.
[図 13]注入ヘッドの変形例を示す斜視図である。 FIG. 13 is a perspective view showing a modification of the injection head.
[図 14]薬液注入システムの変形例で注入ヘッドに薬液シ"ソ、 、ン" [Fig.14] In the modified example of the chemical solution injection system, the chemical solution is applied to the injection head.
装着される状態を示す斜視図である。 It is a perspective view which shows the state mounted | worn.
符号の説明 Explanation of symbols
100 薬液注入装置  100 chemical injection device
110、 170 注入ヘッド  110, 170 injection head
114、 174 本体保持部材  114, 174 Body holding member
115 保持凹部  115 Holding recess
116 ピストン駆動機構  116 Piston drive mechanism
121、 173 フランジ保持咅附  121, 173 With flange holder
130 RFIDリーダ  130 RFID reader
131 アンテナシート  131 Antenna sheet
133 貫通孔  133 Through hole
135 フェライトシート  135 Ferrite sheet
140 コンピュータユニット  140 computer units
150 動作制御手段  150 Operation control means
151 データ記憶手段 152 データ照合手段 151 Data storage means 152 Data collation means
153 警告出力手段  153 Warning output means
154 データ蓄積手段  154 Data storage means
156 データ保持手段  156 Data holding means
157 表示制御手段  157 Display control means
158 注入制御手段  158 Injection control means
171 ディスプレイパネノレ  171 display panel
200 薬液シリンジ  200 chemical syringe
210 シリンダ部材  210 Cylinder member
211 シリンダ本体  211 Cylinder body
213 シリンダフランジ  213 Cylinder flange
220 ピストン部材  220 Piston member
230 RFIDタグ  230 RFID tag
232 回路チップ  232 circuit chip
233 タグアンテナ  233 tag antenna
300 CTスキャナ  300 CT scanner
400 シリンダアダプタ  400 cylinder adapter
1000 薬液注入システム  1000 chemical injection system
発明を実施するための最良の形態  BEST MODE FOR CARRYING OUT THE INVENTION
[0034] [実施の形態の構成]  [Configuration of the embodiment]
本発明の実施の形態を図面を参照して以下に説明する。本形態の薬液注入システ ム 1000は、図 1ないし図 4に示すように、薬液注入装置 100、薬液シリンジ 200、およ び透視撮像装置である CTスキャナ 300、を有しており、詳細には後述するが、造影 剤などの薬液を注入する被験者 (図示せず)カゝら透視画像を撮像する。  Embodiments of the present invention will be described below with reference to the drawings. As shown in FIGS. 1 to 4, the chemical injection system 1000 of this embodiment includes a chemical injection device 100, a chemical syringe 200, and a CT scanner 300 that is a fluoroscopic imaging device. As will be described later, a fluoroscopic image is taken from a subject (not shown) who injects a medical solution such as a contrast medium.
[0035] CTスキャナ 300は、図 4および図 5に示すように、透視撮像ユニット 301と撮像制御 ユニット 302とを有している。透視撮像ユニット 301と撮像制御ユニット 302とは通信 ネットワーク 303で有線接続されている。透視撮像ユニット 301は被験者から透視画 像を撮像し、撮像制御ユニット 302は透視撮像ユニット 301の動作を制御する。 [0036] 薬液シリンジ 200は、図 2および図 6に示すように、シリンダ部材 210とピストン部材 220とを有しており、シリンダ部材 210にピストン部材 220がスライド自在に挿入され ている。シリンダ部材 210は、円筒状のシリンダ本体 211を有しており、このシリンダ 本体 211の閉塞した前端に導管部 212が形成されて 、る。 The CT scanner 300 includes a fluoroscopic imaging unit 301 and an imaging control unit 302, as shown in FIGS. The fluoroscopic imaging unit 301 and the imaging control unit 302 are wiredly connected via a communication network 303. The fluoroscopic imaging unit 301 captures a fluoroscopic image from the subject, and the imaging control unit 302 controls the operation of the fluoroscopic imaging unit 301. As shown in FIG. 2 and FIG. 6, the chemical syringe 200 has a cylinder member 210 and a piston member 220, and the piston member 220 is slidably inserted into the cylinder member 210. The cylinder member 210 has a cylindrical cylinder body 211, and a conduit portion 212 is formed at the closed front end of the cylinder body 211.
[0037] シリンダ部材 210のシリンダ本体 211の後端は開口されており、この開口からシリン ダ本体 211の内部にピストン部材 220が挿入されている。シリンダ部材 210は、シリン ダ本体 211の後端外周に形成された円環状のシリンダフランジ 213を有しており、ピ ストン部材 220は、ピストン本体 221の後端外周に形成された円環状のピストンフラン ジ 222を有している。  [0037] The rear end of the cylinder body 211 of the cylinder member 210 is opened, and the piston member 220 is inserted into the cylinder body 211 from this opening. The cylinder member 210 has an annular cylinder flange 213 formed on the outer periphery of the rear end of the cylinder body 211, and the piston member 220 is an annular piston formed on the outer periphery of the piston body 221. It has flange 222.
[0038] なお、シリンダ部材 210は、非導電体かつ非磁性体である樹脂で形成されており、 例えば、その肉厚は 1.5mm〜2.0mm程度である。本形態の薬液注入システム 1000で は、使用される薬液シリンジ 200の少なくとも一部がプレフィルドタイプである。プレフ ィルドタイプの薬液シリンジ 200は、シリンダ部材 210に薬液が充填された状態で出 荷される。  [0038] The cylinder member 210 is formed of a non-conductive and non-magnetic resin, and has a thickness of about 1.5 mm to 2.0 mm, for example. In the chemical solution injection system 1000 of this embodiment, at least a part of the chemical solution syringe 200 used is a prefilled type. The pre-filled type chemical solution syringe 200 is shipped with the cylinder member 210 filled with the chemical solution.
[0039] 薬液シリンジ 200のシリンダ部材 210には RFIDタグ 230が装着されている。 RFID タグ 230には、その薬液シリンジ 200に関する、名称、プレフィルドタイプ力リフィルタ イブかの識別データ、個体ごとの識別データ、容量、シリンダ部材 210の耐圧、シリン ダ部材 210の内径、ピストン部材 220のストローク、などの各種データが記録されてい る。  The RFID tag 230 is attached to the cylinder member 210 of the chemical syringe 200. The RFID tag 230 includes the name, prefilled type force refilter identification data, identification data for each individual, capacity, cylinder member 210 pressure resistance, cylinder member 210 inner diameter, and piston member 220 stroke. Various data such as, etc. are recorded.
[0040] さらに、その薬液シリンジ 200がプレフィルドタイプの場合、その RFIDタグ 230には 、充填されている薬液に関する、名称、成分、粘度、消費期限、 CT用か MR用かなど の識別データ、などの各種データも記録されている。また、そのプレフィルドタイプの 薬液シリンジ 200に充填されている薬液が造影剤の場合、その RFIDタグ 230には、 注入速度を時間経過により変化させる可変パターン、なども必要により記録されてい る。  [0040] Furthermore, when the chemical syringe 200 is of a prefilled type, the RFID tag 230 has a name, component, viscosity, expiration date, identification data such as whether it is for CT or MR, etc. Various data are also recorded. Further, when the drug solution filled in the prefilled type drug solution syringe 200 is a contrast medium, a variable pattern that changes the injection rate with time is recorded in the RFID tag 230 as necessary.
[0041] RFIDタグ 230は、図 7に示すように、細長形状の榭脂シート 231を有しており、そ の一端近傍に回路チップ 232が封入されている。また、榭脂シート 231には、タグァ ンテナ 233も平面形状で細長形状のループアンテナとしてプリント配線により形成さ れて 、る。タグアンテナ 233は回路チップ 232に結線されて 、る。 As shown in FIG. 7, the RFID tag 230 has a long and narrow resin sheet 231, and a circuit chip 232 is enclosed in the vicinity of one end thereof. In addition, the tag antenna 233 is also formed on the resin sheet 231 by a printed wiring as a planar and elongated loop antenna. It is. The tag antenna 233 is connected to the circuit chip 232.
[0042] RFIDタグ 230は、例えば、榭脂シート 231の表面が白色に形成されており、この表 面に各種の情報を印刷することができる。榭脂シート 231の裏面には粘着材 (図示せ ず)が塗布されており、 RFIDタグ 230は、その粘着材によりシリンダ部材 210の外周 面に貼付することができる。  In the RFID tag 230, for example, the surface of the resin sheet 231 is formed in white, and various information can be printed on this surface. An adhesive material (not shown) is applied to the back surface of the resin sheet 231, and the RFID tag 230 can be attached to the outer peripheral surface of the cylinder member 210 with the adhesive material.
[0043] 薬液シリンジ 200は、図 6および図 8に示すように、シリンダフランジ 213の円形の外 周面 214の相対する位置に一対の平坦部 215が平行に形成されており、これによつ てシリンダフランジ 213は左右対称であるとともに上下対称な構造となっている。  [0043] As shown in Figs. 6 and 8, the chemical syringe 200 has a pair of flat portions 215 formed in parallel at opposite positions of the circular outer peripheral surface 214 of the cylinder flange 213. Thus, the cylinder flange 213 has a left-right symmetry and a vertically symmetrical structure.
[0044] ただし、この薬液シリンジ 200は、例えば、「こちらを上側として使用して下さい」「こ ちらを上側として使用しな 、で下さ 、」などのメッセージが記載されたステッカーがシ リンダ本体 211の外周面に貼付されて 、ることにより (図示せず)、一対の平坦部 215 の一方が上方で他方が下方となるように規定されて 、る。  [0044] However, this chemical syringe 200 has, for example, a sticker with a message such as "Please use this as the upper side" or "Do not use this as the upper side". By being affixed to the outer peripheral surface (not shown), it is defined that one of the pair of flat portions 215 is upward and the other is downward.
[0045] そして、このように上下方向が規定されている薬液シリンジ 200に対し、 RFIDタグ 2 30は、その長手方向がシリンダ部材 210の軸心方向と平行な状態で、シリンダ本体 2 11の下側の外周面に装着されている。  [0045] With respect to the chemical syringe 200 in which the vertical direction is regulated as described above, the RFID tag 230 has a longitudinal direction parallel to the axial direction of the cylinder member 210, and the bottom of the cylinder body 211. It is mounted on the outer peripheral surface.
[0046] 本形態の薬液注入装置 100は、図 3に示すように、互いに別体として構成され通信 ケーブル 102で有線接続されている注入ヘッド 110と注入制御ユニット 101とを有し ている。注入ヘッド 110は、装着される薬液シリンジ 200を駆動して被験者に薬液を 注入する。注入制御ユニット 101は、注入ヘッド 110の動作を制御する。  As shown in FIG. 3, the drug solution injection device 100 of the present embodiment includes an injection head 110 and an injection control unit 101 that are configured separately from each other and are wire-connected by a communication cable 102. The injection head 110 drives the chemical solution syringe 200 to be attached to inject the chemical solution into the subject. The injection control unit 101 controls the operation of the injection head 110.
[0047] 注入ヘッド 110は、キャスタスタンド 111の上端に可動アーム 112を介して装着され ており、図 2に示すように、薬液シリンジ 200が上方力も着脱自在に装着される。注入 ヘッド 110は、外装としてヘッドハウジング 113を有している。ヘッドハウジング 113は 、全体的に樹脂で形成されているが、図 1および図 2に示すように、前端上部のみ金 属製の本体保持部材 114で形成されて 、る。  The injection head 110 is attached to the upper end of the caster stand 111 via the movable arm 112, and as shown in FIG. The injection head 110 has a head housing 113 as an exterior. The head housing 113 is entirely formed of a resin, but as shown in FIGS. 1 and 2, only the upper part of the front end is formed of a metal main body holding member 114.
[0048] より具体的には、本体保持部材 114は、アルミニウム合金などの高強度な非磁性体 の金属により形成されており、上方カゝら挿入されるシリンダ本体 211を保持する半円 筒状の保持凹部 115が上面に形成されている。本体保持部材 114の後端には、シリ ンダ保持機構 120が配置されている。シリンダ保持機構 120は、ステンレス合金など の高強度な金属で形成されて 、る。 More specifically, the main body holding member 114 is formed of a high-strength nonmagnetic metal such as an aluminum alloy, and has a semi-cylindrical shape that holds the cylinder main body 211 inserted from the upper side. The holding recess 115 is formed on the upper surface. A cylinder holding mechanism 120 is disposed at the rear end of the main body holding member 114. Cylinder holding mechanism 120 is stainless steel alloy etc. It is made of high strength metal.
[0049] このシリンダ保持機構 120は、左右一対のフランジ保持部材 121を有している。左 右一対のフランジ保持部材 121は、固定保持部材 122と可動保持部材 123とを有し ている。固定保持部材 122は、本体保持部材 114の後端に固定されており、可動保 持部材 123は、本体保持部材 114の後端に左右方向に開閉自在に支持されている 。固定保持部材 122と可動保持部材 123とは、内面に円弧状の保持スリットが形成さ れており、そこに薬液シリンジ 200のシリンダフランジ 213が係合する。  This cylinder holding mechanism 120 has a pair of left and right flange holding members 121. The pair of left and right flange holding members 121 includes a fixed holding member 122 and a movable holding member 123. The fixed holding member 122 is fixed to the rear end of the main body holding member 114, and the movable holding member 123 is supported by the rear end of the main body holding member 114 so as to be opened and closed in the left-right direction. The fixed holding member 122 and the movable holding member 123 are formed with arc-shaped holding slits on the inner surface, and the cylinder flange 213 of the drug solution syringe 200 is engaged therewith.
[0050] 注入ヘッド 110の後部には、ピストン駆動機構 116が搭載されている。ピストン駆動 機構 116は、薬液シリンジ 200のピストンフランジ 222を保持して前後方向にスライド 移動させる。ピストン駆動機構 116は、図 5に示すように、 AC(Alternating Current)モ ータなどの駆動モータ 117を駆動源として有しており、ボールネジ機構 (図示せず)な どによりピストン部材 220をスライド移動させる。  A piston drive mechanism 116 is mounted on the rear portion of the injection head 110. The piston driving mechanism 116 holds the piston flange 222 of the chemical syringe 200 and slides it back and forth. As shown in FIG. 5, the piston drive mechanism 116 has a drive motor 117 such as an AC (Alternating Current) motor as a drive source, and the piston member 220 is slid by a ball screw mechanism (not shown) or the like. Move.
[0051] また、ピストン駆動機構 116にはロードセル 118も内蔵されている。ロードセル 118 は、ピストン部材 220を押圧する圧力を検出する。なお、ヘッドハウジング 113の内部 左右には、前後方向に細長い金属フレーム (図示せず)が配置されており、この金属 フレームによりピストン駆動機構 116と本体保持部材 114とが連結されて 、る。  [0051] The piston drive mechanism 116 also includes a load cell 118. The load cell 118 detects the pressure that presses the piston member 220. A long and narrow metal frame (not shown) is disposed on the left and right sides of the head housing 113, and the piston drive mechanism 116 and the main body holding member 114 are connected by the metal frame.
[0052] 本形態の薬液注入装置 100は、例えば、表面にリーダアンテナ (図示せず)が実装 されたチップ部品として形成されて 、る RFIDリーダ 130を有して 、る。 RFIDリーダ 1 30は、図 1に示すように、リーダアンテナが下側に位置するように本体保持部材 114 の下面に配置されている。  [0052] The chemical injection device 100 according to the present embodiment includes, for example, an RFID reader 130 formed as a chip component having a reader antenna (not shown) mounted on the surface thereof. As shown in FIG. 1, the RFID reader 130 is disposed on the lower surface of the main body holding member 114 so that the reader antenna is positioned on the lower side.
[0053] さらに、本形態の薬液注入装置 100は、アンテナシート 131を有している。アンテナ シート 131は、回路チップ 232が省略された RFIDタグ 230に相当する構造を有して いる。つまり、アンテナシート 131は、細長形状の榭脂シートに平面形状のループア ンテナがプリント配線で細長形状に形成されており、 RFIDタグ 230とともに既製品と して量産されている。なお、このようなアンテナシート 131および RFIDタグ 230は、例 えば、 18mm X 50mmの略長方形に形成されており、 13.56MHzの周波数で無線通信 する MMタグ (商品名称)などがある。  Furthermore, the chemical injection device 100 of this embodiment has an antenna sheet 131. The antenna sheet 131 has a structure corresponding to the RFID tag 230 from which the circuit chip 232 is omitted. That is, the antenna sheet 131 is formed as an off-the-shelf product together with an RFID tag 230 in which a planar loop antenna is formed into a slender shape with printed wiring on a slender resin sheet. The antenna sheet 131 and the RFID tag 230 are formed in a substantially rectangular shape of 18 mm × 50 mm, for example, and include an MM tag (product name) that performs wireless communication at a frequency of 13.56 MHz.
[0054] そして、本形態の薬液注入装置 100では、本体保持部材 114に、保持凹部 115の 外面(下面)から内面 (底面)まで、保持凹部 115をその厚み方向に貫通する横長の 貫通孔 133が形成されている。アンテナシート 131は、この貫通孔 133に揷通されて いる。 [0054] In the chemical injection device 100 of the present embodiment, the main body holding member 114 has the holding recess 115. From the outer surface (lower surface) to the inner surface (bottom surface), a horizontally long through-hole 133 that penetrates the holding recess 115 in the thickness direction is formed. The antenna sheet 131 is passed through the through hole 133.
[0055] アンテナシート 131の貫通孔 133から上方に位置する一端は後方に曲折されてお り、シート状の高透磁率な強磁性体であるフェライトシート 135を介して保持凹部 115 の底面に配置されている。このため、詳細には後述する力 注入ヘッド 110に薬液シ リンジ 200が適切に装着されると、その RFIDタグ 230が平行に対向して良好に電磁 結合される位置に、アンテナシート 131の一端は配置されて!、る。  [0055] One end located above the through hole 133 of the antenna sheet 131 is bent backward, and is disposed on the bottom surface of the holding recess 115 via a ferrite sheet 135 that is a sheet-like high-permeability ferromagnetic material. Has been. For this reason, when the chemical syringe 200 is properly attached to the force injection head 110, which will be described in detail later, one end of the antenna sheet 131 is placed at a position where the RFID tag 230 is parallelly opposed and well electromagnetically coupled. Arranged! RU
[0056] また、アンテナシート 131の貫通孔 133から下方に位置する他端は前方に曲折され ており、 RFIDリーダ 130の下面に配置されている。なお、前述のように RFIDリーダ 1 30は、リーダアンテナが下側に位置しているので、このリーダアンテナとアンテナシ ート 131の他端とは平行に対向して良好に電磁結合されている。  [0056] The other end of the antenna sheet 131 located below the through hole 133 is bent forward and disposed on the lower surface of the RFID reader 130. Note that, as described above, since the reader antenna of the RFID reader 130 is located on the lower side, the reader antenna and the other end of the antenna sheet 131 face each other in parallel and are well electromagnetically coupled. .
[0057] また、図 1は模式図であるため、本体保持部材 114の保持凹部 115の底面に位置 するフェライトシート 135およびアンテナシート 131が突出している力 実際にはフエ ライトシート 135およびアンテナシート 131の厚さは無視できる程度であり、保持凹部 115への薬液シリンジ 200の装着を阻害するようなことはな 、。  Further, FIG. 1 is a schematic diagram, and thus the force by which the ferrite sheet 135 and the antenna sheet 131 located on the bottom surface of the holding recess 115 of the main body holding member 114 protrude is actually the ferrite sheet 135 and the antenna sheet 131. The thickness of this is negligible and does not obstruct the mounting of the chemical syringe 200 in the holding recess 115.
[0058] 上述のような構造の注入ヘッド 110と通信ケーブル 102で結線されて!、る注入制御 ユニット 101は、図 5に示すように、コンピュータユニット 140が内蔵されており、 CTス キヤナ 300の撮像制御ユニット 302とも通信ネットワーク 304で有線接続されている。  [0058] The injection control unit 101 connected to the injection head 110 having the structure as described above by the communication cable 102 has a built-in computer unit 140 as shown in FIG. The imaging control unit 302 is also connected by wire via a communication network 304.
[0059] 注入制御ユニット 101は、図 3に示すように、操作パネル 103、ディスプレイデバイス である液晶ディスプレイ 104、スピーカユニット 105、等が本体ハウジング 106の前面 に配置されており、別体のコントローラユニット 107が接続ケーブル 108で有線接続 されている。  [0059] As shown in FIG. 3, the injection control unit 101 includes an operation panel 103, a liquid crystal display 104 as a display device, a speaker unit 105, and the like arranged on the front surface of the main body housing 106, and is a separate controller unit. 107 is wired with connection cable 108.
[0060] 本形態の薬液注入装置 100は、図 5に示すように、上述した RFIDリーダ 130など の各種デバイスがコンピュータユニット 140に接続されており、このコンピュータュ-ッ ト 140が各種デバイスを統合制御する。コンピュータユニット 140は、いわゆるワンチ ップマイコンであり、 CPU(Central Processing Unit) 141, ROM(Read Only Memory) 142、 RAM(Random Access Memory) 143, l/F(Interface)144,等のハードウェアを有している。コンピュータュニ ット 140は、その ROM142などの情報記憶媒体に適切なコンピュータプログラムがフ アームウェアなどで実装されており、そのコンピュータプログラムに対応して CPU141 が各種の処理動作を実行する。 [0060] As shown in FIG. 5, in the chemical injection device 100 of this embodiment, various devices such as the above-described RFID reader 130 are connected to the computer unit 140, and the computer unit 140 integrates the various devices. Control. The computer unit 140 is a so-called one-chip microcomputer, which includes a CPU (Central Processing Unit) 141, a ROM (Read Only Memory) 142, and a RAM (Random Access). Memory) 143, l / F (Interface) 144, and the like. In the computer unit 140, an appropriate computer program is mounted on the information storage medium such as the ROM 142 by using firmware or the like, and the CPU 141 executes various processing operations corresponding to the computer program.
[0061] 本形態の薬液注入装置 100は、上述のように実装されているコンピュータプロダラ ムに対応してコンピュータユニット 140が動作することにより、図 9に示すように、動作 制御手段 150を論理的に有しており、この動作制御手段 150が、データ記憶手段 15 1、データ照合手段 152、警告出力手段 153、データ蓄積手段 154、データ保持手 段 156、表示制御手段 157、注入制御手段 158、等の各種手段を論理的に有して いる。 [0061] In the chemical injection device 100 of this embodiment, the computer unit 140 operates corresponding to the computer program implemented as described above, whereby the operation control means 150 is logically operated as shown in FIG. The operation control means 150 includes a data storage means 151, a data collating means 152, a warning output means 153, a data storage means 154, a data holding means 156, a display control means 157, and an injection control means 158. , Etc. have various means logically.
[0062] 動作制御手段 150は、 ROM142などに実装されているコンピュータプログラムと R FIDタグ 230から無線受信された記録データとに対応して CPU141が所定動作を実 行する機能に相当する。  [0062] The operation control means 150 corresponds to a function in which the CPU 141 executes a predetermined operation corresponding to the computer program installed in the ROM 142 or the like and the recording data wirelessly received from the R FID tag 230.
[0063] データ記憶手段 151は、 CPU 141がデータ認識する RAM 143の記憶領域などに 相当し、所定の確認条件を記憶している。データ照合手段 152は、記憶されている 確認条件と RFIDタグ 230から無線受信された記録データとを照合する。警告出力 手段 153は、照合結果に対応して確認警告を出力する。  The data storage unit 151 corresponds to a storage area of the RAM 143 that the CPU 141 recognizes data, and stores predetermined confirmation conditions. The data collating means 152 collates the stored confirmation conditions with the record data received wirelessly from the RFID tag 230. The warning output means 153 outputs a confirmation warning corresponding to the collation result.
[0064] より具体的には、 RAM143には、使用できる薬液シリンジ 200の識別データが確 認条件として登録されており、 RFIDリーダ 130で薬液シリンジ 200の RFIDタグ 230 から記録データが無線受信されると、その無線受信された薬液シリンジ 200の識別デ ータが RAM143に登録されている識別データと照合される。  More specifically, identification data of the usable chemical syringe 200 is registered as a confirmation condition in the RAM 143, and the RFID reader 130 wirelessly receives the recording data from the RFID tag 230 of the chemical syringe 200. Then, the wirelessly received identification data of the chemical syringe 200 is collated with the identification data registered in the RAM 143.
[0065] これで無線受信された識別データが登録されていないと、「この製品は使用可能な シリンジとして登録されておりません、使用可能力確認して下さ!/、」などのガイダンスメ ッセージが確認警告として液晶ディスプレイ 104で表示されるとともにスピーカュ-ッ ト 105で音声出力される。  [0065] If the wirelessly received identification data is not registered, a guidance message such as "This product is not registered as a usable syringe, please check its usability! /," Is displayed. Is displayed on the liquid crystal display 104 as a confirmation warning, and sound is output from the speaker 105.
[0066] また、 RAM143には、確認条件として現在日時が日々更新されて保持されており、 薬液シリンジ 200の RFIDタグ 230から消費期限が無線受信されると、その消費期限 と現在日時が照合される。これで現在日時が消費期限を超過していると、「この製品 は消費期限を過ぎて ヽます。新 Uヽ製品を使用して下さ!ヽ」などのガイダンスメッセ一 ジが確認警告として液晶ディスプレイ 104で表示されるとともにスピーカユニット 105 で音声出力される。 [0066] Further, the RAM 143 holds the current date and time updated daily as a confirmation condition, and when the expiration date is received wirelessly from the RFID tag 230 of the chemical syringe 200, the expiration date and the current date and time are collated. The If the current date and time exceeds the expiration date, "This product Will expire after the expiration date. Guidance messages such as “Use a new U! Product!” Are displayed on the LCD 104 as a confirmation warning and also output by the speaker unit 105.
[0067] さらに、プレフィルドタイプの薬液シリンジ 200では、個体ごとの製造番号も RFIDタ グ 230に記録されているので、データ蓄積手段 154は、注入ヘッド 110に装着されて 注入動作が実行されたプレフィルドタイプの薬液シリンジ 200の製造番号を記憶する  [0067] Furthermore, in the prefilled type liquid syringe 200, the serial number of each individual is also recorded in the RFID tag 230, so the data storage means 154 is attached to the injection head 110 and the injection operation is executed. Memorize the serial number of type 200 chemical syringe
[0068] この場合、データ照合手段 152は、記憶されている製造番号と RFIDタグ 230から 無線受信された製造番号とを照合する。照合された製造番号が一致すると、警告出 力手段 153は、「このプレフィルドシリンジは過去に使用されています。新しい製品を 使用して下さ!/、」などのガイダンスメッセージを確認警告として液晶ディスプレイ 104 に表示させるとともにスピーカユニット 105に音声出力させる。 In this case, the data collating unit 152 collates the stored manufacturing number with the manufacturing number wirelessly received from the RFID tag 230. If the matched serial numbers match, the warning output means 153 will check the guidance message such as “This prefilled syringe has been used in the past. Please use a new product! And the speaker unit 105 outputs sound.
[0069] データ保持手段 156は、 RFIDタグ 230から無線受信した記録データを保持する。  [0069] The data holding unit 156 holds the recording data wirelessly received from the RFID tag 230.
表示制御手段 157は、保持された記録データを液晶ディスプレイ 104に表示させる。 注入制御手段 158は、保持された記録データに対応してピストン駆動機構 116の動 作を制御する。  The display control means 157 displays the stored recording data on the liquid crystal display 104. The injection control means 158 controls the operation of the piston drive mechanism 116 in accordance with the stored recording data.
[0070] より具体的には、薬液シリンジ 200の RFIDタグ 230には、その薬液シリンジ 200の 名称や耐圧や容量などのデータと、その薬液シリンジ 200に充填されている薬液の 名称や成分や消費期限などのデータとが記録されているので、これらの記録データ が RAM143に一時保持されて液晶ディスプレイ 104で表示される。  [0070] More specifically, the RFID tag 230 of the chemical syringe 200 includes data such as the name, pressure resistance, and capacity of the chemical syringe 200, and the name, components, and consumption of the chemical solution filled in the chemical syringe 200. Since data such as a time limit is recorded, the recorded data is temporarily stored in the RAM 143 and displayed on the liquid crystal display 104.
[0071] また、薬液シリンジ 200の RFIDタグ 230にピストン駆動機構 116の制御データが記 録されていた場合、その制御データが RAM143に保持される。 CPU141は保持さ れた制御データに対応してピストン駆動機構 116の動作を制御する。例えば、薬液 シリンジ 200の RFIDタグ 230に造影剤の注入速度を時間経過により変化させる可変 パターンが記録されていた場合、その可変パターンに対応して CPU141がピストン 駆動機構 116の動作速度を経時的に変化させる。  [0071] When the control data of the piston drive mechanism 116 is recorded in the RFID tag 230 of the chemical syringe 200, the control data is stored in the RAM 143. The CPU 141 controls the operation of the piston drive mechanism 116 in accordance with the held control data. For example, if a variable pattern that changes the injection speed of the contrast agent over time is recorded in the RFID tag 230 of the chemical syringe 200, the CPU 141 changes the operating speed of the piston drive mechanism 116 over time corresponding to the variable pattern. Change.
[0072] さらに、薬液シリンジ 200の RFIDタグ 230〖こ、その薬液シリンジ 200の而圧が記録 されていると、 CPU141はロードセル 118の検出圧力に対応して、 RAM143に保持 された耐圧を超過しないようにピストン駆動機構 116の動作を制御する。また、薬液 シリンジ 200の RFIDタグ 230に、その薬液シリンジに充填されている薬液の容量が 記録されていると、 CPU141は RAM143に保持された容量に対応してピストン駆動 機構 116の動作を制御する。 [0072] Further, when the RFID tag 230 of the chemical syringe 200 and the metapressure of the chemical syringe 200 are recorded, the CPU 141 holds the RAM 141 corresponding to the detected pressure of the load cell 118. The operation of the piston drive mechanism 116 is controlled so as not to exceed the set pressure resistance. In addition, when the RFID tag 230 of the drug solution syringe 200 records the volume of the drug solution filled in the drug solution syringe, the CPU 141 controls the operation of the piston drive mechanism 116 in accordance with the volume held in the RAM 143. .
[0073] 上述のような薬液注入装置 100の各種手段は、必要により液晶ディスプレイ 104な どのハードウ アを利用して実現される力 その主体は、 ROM142等の情報記憶媒 体に格納されたリソースおよびコンピュータプログラムに対応してハードウェアである CPU141が機能することにより実現されている。  [0073] Various means of the chemical injection device 100 as described above are powers that are realized by using hardware such as the liquid crystal display 104 as necessary. The main means are resources stored in an information storage medium such as the ROM 142 and the like. This is realized by the function of the CPU 141 which is hardware corresponding to the computer program.
[0074] このようなコンピュータプログラムは、例えば、 RFIDタグ 230から RFIDリーダ 130で 記録データが無線受信されると、 RAM143などに記憶されて ヽる確認条件と RFID タグ 230から無線受信された記録データとを照合すること、その照合結果に対応して 液晶ディスプレイ 104の表示などで確認警告を出力すること、装着されて注入動作が 実行された薬液シリンジ 200の製造番号を RAM143などに記憶させること、その記 憶されている製造番号と RFIDタグ 230から無線受信された製造番号とを照合するこ と、その照合結果に対応して液晶ディスプレイ 104の表示などで確認警告を出力す ること、 RFIDタグ 230から無線受信された記録データを RAM 143などに保持させる こと、保持された記録データを液晶ディスプレイ 104に表示させること、保持された記 録データに対応してピストン駆動機構 116の動作を制御すること、等の処理動作を C PU141等に実行させるためのソフトウェアとして RAM143等の情報記憶媒体に格 納されている。  [0074] Such a computer program is, for example, when the recording data is received wirelessly from the RFID tag 230 by the RFID reader 130, and the confirmation condition stored in the RAM 143 or the like and the recording data received wirelessly from the RFID tag 230. In response to the comparison result, a confirmation warning is output on the display of the liquid crystal display 104, etc., the manufacturing number of the chemical syringe 200 that has been installed and the injection operation has been performed is stored in the RAM 143, etc. The stored serial number and the serial number received wirelessly from the RFID tag 230 are collated, and a confirmation warning is output on the LCD 104 according to the collation result. The recording data received wirelessly from the 230 is stored in the RAM 143 or the like, the stored recording data is displayed on the liquid crystal display 104, and the stored recording data is stored. It is stored in an information storage medium such as the RAM 143 as software for causing the CPU 141 to execute processing operations such as controlling the operation of the piston drive mechanism 116 corresponding to the data.
[0075] [実施の形態の作用]  [0075] [Effect of the embodiment]
上述のような構成において、本形態の薬液注入システム 1000を利用する場合、図 4に示すように、 CTスキャナ 300の撮像ユニット 301の近傍に薬液注入装置 100の 注入ヘッド 110が配置され、使用する薬液シリンジ 200などが用意される。そして、作 業者は注入ヘッド 110の可動保持部材 123を開放させ、そこにシリンダフランジ 213 が挿入されるように薬液シリンジ 200を保持凹部 115に装着する。薬液シリンジ 200 の装着後、作業者は可動保持部材 123を閉止する。  In the configuration as described above, when using the chemical injection system 1000 of this embodiment, as shown in FIG. 4, the injection head 110 of the chemical injection device 100 is arranged and used in the vicinity of the imaging unit 301 of the CT scanner 300. A chemical syringe 200 is prepared. Then, the operator opens the movable holding member 123 of the injection head 110 and attaches the drug solution syringe 200 to the holding recess 115 so that the cylinder flange 213 is inserted therein. After the chemical solution syringe 200 is attached, the operator closes the movable holding member 123.
[0076] 前述のように薬液シリンジ 200はシリンダ本体 211に貼付されて 、るステッカーなど により上下方向が指定されているので、薬液シリンジ 200を装着する際、図 1および 図 8(b)に示すように、作業者は RFIDタグ 230が下方に位置する適切な状態で、薬 液シリンジ 200を薬液注入装置 100に装着することになる。 [0076] As described above, the chemical syringe 200 is affixed to the cylinder body 211, such as a sticker. Since the vertical direction is specified by the operator, when attaching the chemical syringe 200, as shown in FIG. 1 and FIG. 8 (b), the operator must properly place the chemical syringe with the RFID tag 230 positioned below. 200 is attached to the chemical injection device 100.
[0077] すると、 RFIDタグ 230とアンテナシート 131の一端とが平行に対向して良好に電磁 結合されるので、このアンテナシート 131により RFIDタグ 230と RFIDリーダ 130との 無線通信が中継され、 RFIDタグ 230と RFIDリーダ 130とが良好に無線通信するこ とになる。 Then, since the RFID tag 230 and one end of the antenna sheet 131 face each other in parallel and are well electromagnetically coupled, the antenna sheet 131 relays wireless communication between the RFID tag 230 and the RFID reader 130, and the RFID The tag 230 and the RFID reader 130 can communicate wirelessly satisfactorily.
[0078] そして、本形態の薬液注入装置 100では、図 10に示すように、注入ヘッド 110に薬 液シリンジ 200が適切に装着されて RFIDリーダ 130により RFIDタグ 230から記録デ ータが無線受信されると (ステップ Sl)、コンピュータユニット 140により、受信データと RAM143に登録されている確認条件とが整合している力否かが判断される (ステップ S2)。  Then, in the chemical injection device 100 of this embodiment, as shown in FIG. 10, the chemical syringe 200 is appropriately attached to the injection head 110 and the RFID reader 130 wirelessly receives the recorded data from the RFID tag 230. If so (step Sl), the computer unit 140 determines whether or not the received data matches the confirmation condition registered in the RAM 143 (step S2).
[0079] 確認条件としては、使用できる薬液シリンジ 200の識別データが登録されて 、る。よ つて、 RFIDタグ 230から無線受信された識別データが確認条件として登録されて ヽ ないと、「この製品は使用可能なシリンジとして登録されておりません、使用可能か確 認して下さ ヽ」などのガイダンスメッセージが確認警告として液晶ディスプレイ 104で 表示されるとともにスピーカユニット 105で音声出力される (ステップ S3)。  [0079] As the confirmation condition, identification data of the usable drug solution syringe 200 is registered. Therefore, if the identification data received wirelessly from the RFID tag 230 is not registered as a confirmation condition, `` This product is not registered as a usable syringe, please confirm that it can be used. '' Are displayed on the liquid crystal display 104 as confirmation warnings and are also output by the speaker unit 105 (step S3).
[0080] このため、例えば、その薬液注入装置 100で使用できない薬液シリンジ 200や、消 費期限を超過した薬液シリンジ 200などを使用しょうとすると確認警告が出力されるこ とになり、各種の医療ミスを良好に防止することができる。さらに、薬液シリンジ 200の 識別データが確認条件に整合すると (ステップ S2)、 RFIDタグ 230から無線受信され た製造番号と RAM143に登録されている製造番号とが照合される (ステップ S5)。  [0080] For this reason, for example, if you try to use a chemical syringe 200 that cannot be used with the chemical injection device 100 or a chemical syringe 200 that has exceeded its expiry date, a confirmation warning will be output, and various medical Mistakes can be prevented well. Further, when the identification data of the chemical syringe 200 matches the confirmation condition (step S2), the serial number received wirelessly from the RFID tag 230 and the serial number registered in the RAM 143 are collated (step S5).
[0081] 照合された製造番号が一致すると「このシリンジは過去に使用されています。新しい 製品を使用して下さ ヽ」などのガイダンスメッセージが確認警告として液晶ディスプレ ィ 104とスピーカユニット 105とで出力されるので (ステップ S3)、一度の使用で廃棄す べき薬液シリンジ 200が何度も使用される医療ミスなどを簡単かつ確実に防止するこ とがでさる。  [0081] Guidance messages such as “This syringe has been used in the past. Please use a new product” will be output on the LCD display 104 and the speaker unit 105 as confirmation warnings if the matched serial numbers match. Therefore (step S3), it is possible to easily and reliably prevent medical mistakes and the like in which the chemical syringe 200 that should be discarded after one use is used many times.
[0082] 一方、適切な薬液シリンジ 200の RFIDタグ 230から薬液注入装置 100に無線受信 された記録データは、例えば、「〜(製造メーカ)製の造影シリンジ〜 (名称)が装着され ました。製造番号〜、薬液名称〜、薬液種別〜、容量〜、耐圧〜、 ···」などとして液 晶ディスプレイ 104に表示されるので (ステップ S6)、作業者は使用する薬液シリンジ 2 00などの各種データを簡単かつ確実に確認することができる。 [0082] On the other hand, wireless reception from the RFID tag 230 of the appropriate chemical syringe 200 to the chemical injection device 100 The recorded data is, for example, “~ (Manufacturer) Contrast Syringe ~ (Name) was installed. Serial number ~, Chemical name ~, Chemical type ~, Volume ~, Pressure resistance ~, ..." Is displayed on the liquid crystal display 104 (step S6), so that the operator can easily and surely confirm various data such as the chemical syringe 200 used.
[0083] なお、 RFIDタグ 230には、表示の対象となる各種データと、対象とならない各種デ ータとが記録されているので、例えば、その各種データごとに表示の対象となるかどう 力が 2値フラグで設定されており、薬液注入装置 100は、 RFIDタグ 230から無線受 信された記録データ力も適切な一部を表示する。  [0083] Since the RFID tag 230 stores various data to be displayed and various data not to be displayed, for example, whether or not each of the various data is to be displayed. Is set with a binary flag, and the chemical injection device 100 displays an appropriate part of the recording data force received wirelessly from the RFID tag 230.
[0084] さらに、薬液シリンジ 200の RFIDタグ 230から薬液注入装置 100に無線受信され た記録データに「耐圧」や「容量」や「造影剤の注入速度を時間経過により変化させる 可変パターン」などの制御データが内包されていた場合、その制御データがコンビュ ータユニット 140の RAM143に設定される (ステップ S7)。 RFIDタグ 230から無線受 信された記録データに制御データが設定されて!、な力つた場合は、デフォルトの制 御データが設定される。  [0084] Further, the recording data received wirelessly from the RFID tag 230 of the chemical syringe 200 to the chemical injection device 100 includes "pressure resistance", "capacity", and "variable pattern that changes the injection speed of the contrast medium over time". If the control data is included, the control data is set in the RAM 143 of the converter unit 140 (step S7). If the control data is set in the record data received wirelessly from the RFID tag 230 !, the default control data is set.
[0085] 上述のように薬液注入装置 100に装着された薬液シリンジ 200が延長チューブ (図 示せず)などで被験者に連結されてから、作業者により操作パネル 103に作業開始 が入力操作されると、これを検知した薬液注入装置 100は (ステップ S8)、作業開始を CTスキャナ 300にデータ送信する (ステップ S 11)。  [0085] As described above, when the chemical syringe 200 attached to the chemical injection device 100 is connected to the subject by an extension tube (not shown) or the like, the operator inputs an operation start to the operation panel 103. The chemical injection device 100 that has detected this (step S8) transmits the start of work to the CT scanner 300 (step S11).
[0086] 図 12に示すように、このように薬液注入装置 100から作業開始をデータ受信した C Tスキャナ 300は (ステップ T2)、作業開始を薬液注入装置 100にデータ返信して撮 像動作を実行する (ステップ Τ8)。このため、本形態の薬液注入システム 1000では、 薬液注入装置 100の薬液注入に CTスキャナ 300の画像撮像が追従することになる  [0086] As shown in FIG. 12, the CT scanner 300 that has received the work start data from the chemical injection device 100 in this way (step T2) returns the work start to the chemical injection device 100 and executes the imaging operation. (Step Τ8). For this reason, in the chemical injection system 1000 of this embodiment, the imaging of the CT scanner 300 follows the chemical injection of the chemical injection device 100.
[0087] なお、本形態の薬液注入システム 1000では、図 10および図 12に示すように、前述 のように薬液注入装置 100が準備完了の状態で (ステップ S8〜S 10)、 CTスキャナ 3 00に撮像開始が入力操作された場合も (ステップ Tl)、 CTスキャナ 300の画像撮像 に薬液注入装置 100の薬液注入が追従する (ステップ T4, T6〜, S9, S18〜)。この ため、本形態の薬液注入システム 1000では、造影剤が的確なタイミングで注入され る被験者カゝら透視画像を的確なタイミングで撮像することができる。 In the chemical injection system 1000 of this embodiment, as shown in FIGS. 10 and 12, with the chemical injection device 100 being ready as described above (steps S8 to S10), the CT scanner 300 Even when the start of imaging is input (step Tl), the chemical injection of the chemical injection device 100 follows the imaging of the CT scanner 300 (steps T4, T6˜, S9, S18˜). Therefore, in the chemical injection system 1000 of this embodiment, the contrast medium is injected at an accurate timing. A fluoroscopic image can be taken at an appropriate timing.
[0088] そして、本形態の薬液注入装置 100では、図 11に示すように、薬液注入の一連の 作業を実行する場合 (ステップ S18〜)、その注入開始力 経過時間が計測され (ステ ップ S19)、その経過時間と RFIDタグ 230から無線受信された制御データとに対応し てピストン駆動機構 116の動作がリアルタイムに制御される (ステップ S22)。  [0088] Then, in the chemical injection device 100 of the present embodiment, as shown in Fig. 11, when a series of operations of chemical injection is performed (from step S18), the injection start force elapsed time is measured (step S18). S19), the operation of the piston drive mechanism 116 is controlled in real time in accordance with the elapsed time and the control data wirelessly received from the RFID tag 230 (step S22).
[0089] さらに、本形態の薬液注入装置 100では、例えば、薬液シリンジ 200の RFIDタグ 2 30に造影剤の注入速度を時間経過により変化させる可変パターンが記録されてい た場合、その可変パターンに対応してピストン駆動機構 116の動作速度を経時的に 変化させる。  [0089] Furthermore, in the chemical injection device 100 of the present embodiment, for example, when a variable pattern that changes the injection speed of the contrast agent over time is recorded on the RFID tag 230 of the chemical syringe 200, it corresponds to the variable pattern. Thus, the operating speed of the piston drive mechanism 116 is changed over time.
[0090] 従って、最適な造影度を良好に維持することができ、造影剤の注入容量を必要最 小限として被験者の身体的な負担を低減することができる。それでいて、複雑な可変 ノターンを薬液注入装置 100に事前に登録しておく必要がなぐ例えば、新規の造 影剤に対応した新規の可変パターンでも簡単に薬液シリンジ 200の RFIDタグ 230 力も薬液注入装置 100に入力することができる。  [0090] Accordingly, it is possible to maintain an optimal contrast level satisfactorily, and to reduce the physical burden on the subject by setting the injection volume of the contrast medium to the minimum necessary. However, it is not necessary to register complex variable patterns in the chemical injection device 100 in advance.For example, even with a new variable pattern corresponding to a new agent, the RFID tag 230 of the chemical syringe 200 Can be entered.
[0091] さらに、上述のようにピストン駆動機構 116が駆動されるとき、ロードセル 118が検出 する応力がコンピュータユニット 140にリアルタイムに受信される (ステップ S20)。そし て、 RFIDタグ 230から無線受信された薬液の粘度ゃシリンダ部材 210の内径などに 対応して、ロードセル 118が検出した応力から薬液の注入圧力が算出され (ステップ S21)、この注入圧力が RFIDタグ 230から無線受信された圧力範囲を満足するよう にピストン駆動機構 116の動作がリアルタイムに制御される (ステップ S22)。  Furthermore, when the piston drive mechanism 116 is driven as described above, the stress detected by the load cell 118 is received in real time by the computer unit 140 (step S20). Then, the injection pressure of the chemical solution is calculated from the stress detected by the load cell 118 corresponding to the viscosity of the chemical solution wirelessly received from the RFID tag 230 and the inner diameter of the cylinder member 210 (step S21). The operation of the piston drive mechanism 116 is controlled in real time so as to satisfy the pressure range wirelessly received from the tag 230 (step S22).
[0092] そして、もしも注入圧力が異常圧力となると確認警告を出力するとともに注入動作を 強制停止させるので (ステップ S23)、異常な圧力で薬液が注入される医療ミスを防止 することができる。上述のように薬液注入装置 100が薬液の圧力を検出するためには 、薬液シリンジ 200のピストン部材 220を押圧する応力だけではなぐシリンダ部材 21 0の内径や薬液の粘度などの各種データが必要となる。しかし、このような各種デー タは RFIDタグ 230により薬液注入装置 100に入力される。このため、作業者が各種 データを薬液注入装置 100に手動入力する煩雑な作業を必要とすることなぐ薬液 シリンジ 200ごと薬液ごとの注入圧力を薬液注入装置 100が的確に検出することが できる。 [0092] If the injection pressure becomes an abnormal pressure, a confirmation warning is output and the injection operation is forcibly stopped (step S23), so that it is possible to prevent a medical error in which the drug solution is injected with an abnormal pressure. As described above, in order for the chemical solution injection device 100 to detect the pressure of the chemical solution, various data such as the inner diameter of the cylinder member 210 and the viscosity of the chemical solution are required in addition to the stress pressing the piston member 220 of the chemical solution syringe 200. Become. However, such various kinds of data are input to the chemical solution injector 100 by the RFID tag 230. For this reason, the chemical injection device 100 can accurately detect the injection pressure for each chemical solution for each chemical solution syringe 200 without requiring the cumbersome work of manually inputting various data into the chemical solution injection device 100. it can.
[0093] なお、本形態の薬液注入システム 1000では、もしも薬液シリンジ 200が薬液注入 装置 100に不適切に装着されると、 RFIDタグ 230がアンテナシート 131の一端と平 行に対向しない。この場合、 RFIDタグ 230とアンテナシート 131の一端とが電磁結 合されないので、 RFIDタグ 230と RFIDリーダ 130とが無線通信しない (ステップ S1)  [0093] In the chemical injection system 1000 of this embodiment, if the chemical syringe 200 is improperly attached to the chemical injection device 100, the RFID tag 230 does not face one end of the antenna sheet 131 in parallel. In this case, since the RFID tag 230 and one end of the antenna sheet 131 are not electromagnetically coupled, the RFID tag 230 and the RFID reader 130 do not communicate wirelessly (step S1).
[0094] このため、例えば、図 8(a)に示すように、フランジ保持部材 121によりシリンダフラン ジ 213が平坦部 215で保持された状態で注入動作が開始されてシリンダ部材 211が 破壊されるようなことがない。また、シリンダフランジ 213の平坦部 215が上下に位置 する状態で薬液シリンジ 200が注入ヘッド 110に装着されても、薬液シリンジ 200が 上下逆様ならば RFIDタグ 230と RFIDリーダ 130とが無線通信しないので (ステップ SI やはり薬液シリンジ 200が上下逆様の状態で注入動作が開始されることもない Therefore, for example, as shown in FIG. 8 (a), the injection operation is started in a state where the cylinder flange 213 is held by the flat portion 215 by the flange holding member 121, and the cylinder member 211 is destroyed. There is no such thing. Further, even if the chemical syringe 200 is mounted on the injection head 110 with the flat portion 215 of the cylinder flange 213 positioned vertically, the RFID tag 230 and the RFID reader 130 do not communicate wirelessly if the chemical syringe 200 is upside down. (Step SI) The injection operation is not started when the chemical syringe 200 is upside down.
[0095] なお、上述のようにピストン駆動機構 116により薬液シリンジ 200が駆動されている ときも、その RFIDタグ 230は RFIDリーダ 130により常時検出されている (ステップ S1 8)。そして、注入作業が完了する以前に (ステップ S32)、上述の検出が中断されると( ステップ S18)、ピストン駆動機構 116による注入動作が中止される (ステップ S28)。 Note that even when the chemical syringe 200 is driven by the piston drive mechanism 116 as described above, the RFID tag 230 is always detected by the RFID reader 130 (step S18). If the above detection is interrupted before completion of the injection operation (step S32) (step S18), the injection operation by the piston drive mechanism 116 is stopped (step S28).
[0096] さらに、「シリンジ脱落を検出しました。〜シリンジの装着を確認して下さい」などのガ ィダンスメッセージが確認警告として液晶ディスプレイ 104で表示されるとともにスピ 一力ユニット 105で音声出力され (ステップ S26)、異常発生および注入中止が CTス キヤナ 300にデータ送信される (ステップ S25, S28)。  [0096] In addition, a guidance message such as "Syringe omission detected-Please confirm the syringe installation" is displayed on the LCD 104 as a confirmation warning and voice output is output from the force unit 105. (Step S26), abnormal occurrence and injection stop are transmitted to CT scanner 300 (Steps S25, S28).
[0097] すると、 CTスキャナ 300は、異常発生をデータ受信すると (ステップ T10)、その異常 発生がガイダンス表示などで確認警告として出力され (ステップ T16)、動作中止をデ ータ受信すると (ステップ T13)、その撮像動作が中止される (ステップ Τ18)。  [0097] Then, when the CT scanner 300 receives an error occurrence data (step T10), the error occurrence is output as a confirmation warning on a guidance display or the like (step T16), and when an operation stop is received (step T13). ), The imaging operation is stopped (step Τ18).
[0098] このため、本形態の薬液注入システム 1000では、薬液シリンジ 200が適切に保持 されて 、な 、状態で薬液注入が実行されることを自動的に防止でき、薬液注入の最 中に薬液シリンジ 200が適切な位置力も脱落したような場合でも、その薬液注入を自 動的に中止させることができる。 [0099] し力も、このように薬液シリンジ 200の適切な装着を検出する機構が、薬液シリンジ 200から薬液注入装置 100に各種データを転送するための、 RFIDタグ 230および R FIDリーダ 130であるので、専用のセンサ機構などを必要とすることなく簡単な構造 で薬液シリンジ 200の適切な装着を検出することができる。 [0098] Therefore, in the chemical solution injection system 1000 of this embodiment, the chemical solution syringe 200 is appropriately held, and the chemical solution injection can be automatically prevented from being executed in a state, and the chemical solution injection is performed during the chemical solution injection. Even when the syringe 200 has fallen out of its proper position force, the injection of the chemical solution can be automatically stopped. [0099] Since the mechanism for detecting appropriate attachment of the chemical syringe 200 is the RFID tag 230 and the R FID reader 130 for transferring various data from the chemical syringe 200 to the chemical injection device 100 in this manner. Therefore, it is possible to detect the appropriate mounting of the chemical syringe 200 with a simple structure without requiring a dedicated sensor mechanism or the like.
[0100] なお、本形態の薬液注入装置 100および CTスキャナ 300は、前述の準備完了の 状態で異常発生が検出されたり (ステップ S10, T3)、動作実行の最中に異常発生が 検出されたりしても (ステップ S23, Τ9)、その異常発生が出力されるとともに (ステップ S26, Τ16)、その動作中止が実行される (ステップ S28, Τ18)。  [0100] It should be noted that the chemical injection device 100 and the CT scanner 300 according to the present embodiment detect the occurrence of abnormality in the above-mentioned preparation completion state (steps S10 and T3), or detect the occurrence of abnormality during the operation execution. Even so (Step S23, Τ9), the abnormality is output (Step S26, Τ16), and the operation is stopped (Step S28, Τ18).
[0101] さらに、その異常発生が他方にもデータ送信されるので (ステップ S25, Τ15)、これ をデータ受信した他方でも (ステップ T10, S24)、やはり異常発生が出力される (ステ ップ T16, S26)0また、一方の動作中止も他方にデータ送信されるので (ステップ S2 7, T17)、これをデータ受信した他方でも (ステップ T13, S31)、その動作中止が実 行される (ステップ T18, S28)。 [0101] Furthermore, since the error occurrence is also transmitted to the other side (step S25, Τ15), the other side that has received this data (step T10, S24) also outputs the abnormality occurrence (step T16). , S26) 0 Since one operation stop is also transmitted to the other (steps S2 and T17), the other side that has received the data (steps T13 and S31) executes the operation stop (step S21). T18, S28).
[0102] なお、一方に動作中止が入力操作されたときも (ステップ S29, Tl l)、その動作中 止が実行されるとともに (ステップ S28, Τ18)、他方にも送信されるので (ステップ S27 , Τ17)、これをデータ受信した他方でも (ステップ T13, S31)、その動作中止が実行 される (ステップ T18, S28)。  [0102] Even when an operation stop is input to one side (step S29, Tl l), the operation stop is executed (step S28, Τ18) and also sent to the other (step S27). , Τ17) On the other side of receiving the data (steps T13 and S31), the operation is stopped (steps T18 and S28).
[0103] また、一方で動作完了が検出されたときも (ステップ S32, T14)、その動作終了が実 行されるとともに (ステップ S33, Τ19)、その動作終了が他方にデータ送信されるので (ステップ S34, Τ20)、これをデータ受信した他方でも (ステップ T12, S31)、その動 作中止が実行される (ステップ T18, S28)。  [0103] When the operation completion is detected on one side (steps S32, T14), the operation end is executed (step S33, Τ19), and the operation end is transmitted to the other side ( In step S34, Τ20), on the other side of receiving the data (step T12, S31), the operation stop is executed (step T18, S28).
[0104] 本形態の薬液注入装置 100では、上述のように注入動作が正常または異常に終了 されると (ステップ S33, S28)、薬液シリンジ 200の RFIDタグ 230から無線受信され た識別データが新規の確認条件として RAM 143に登録される (ステップ S 36)。  [0104] In the chemical injection device 100 of this embodiment, when the injection operation ends normally or abnormally as described above (steps S33, S28), the identification data wirelessly received from the RFID tag 230 of the chemical syringe 200 is new. Is registered in the RAM 143 as the confirmation condition (step S36).
[0105] 本形態の薬液注入装置 100は、最小限の改造で既存の注入ヘッド 110に RFIDリ ーダ 130が搭載されており、この RFIDリーダ 130を薬液シリンジ 200の RFIDタグ 23 0と無線通信させるために、既存のアンテナシート 131を利用することができる。その 結果、薬液注入装置 100の生産性は良好である。 [0106] このことを以下に説明する。まず、前述のようにフランジ保持部材 121を支持する本 体支持部材 114は充分な強度が要求されるため、アルミニウム合金などの金属で形 成されている。そこで、薬液シリンジ 200の RFIDタグ 230と対向する位置に RFIDリ ーダ 130を配置するためには、例えば、本体支持部材 114の保持凹部 115の底面 に凹所を形成し、そこにリーダアンテナが上面に位置するように RFIDリーダ 130を配 置することが想定できる (図示せず)。 [0105] The chemical injection device 100 of this embodiment is equipped with the RFID reader 130 on the existing injection head 110 with minimal modifications, and this RFID reader 130 is wirelessly communicated with the RFID tag 230 of the chemical syringe 200. In order to achieve this, the existing antenna sheet 131 can be used. As a result, the productivity of the chemical injection device 100 is good. This will be described below. First, as described above, the main body support member 114 that supports the flange holding member 121 is formed of a metal such as an aluminum alloy because sufficient strength is required. Therefore, in order to place the RFID reader 130 at a position facing the RFID tag 230 of the chemical syringe 200, for example, a recess is formed in the bottom surface of the holding recess 115 of the main body support member 114, and a reader antenna is provided there. It can be assumed that the RFID reader 130 is arranged so as to be located on the upper surface (not shown).
[0107] しかし、これでは RFIDリーダ 130のリーダアンテナの近傍に金属製の本体支持部 材 114が位置することになり、この本体支持部材 114により RFIDリーダ 130と RFID タグ 230との無線通信が阻害されることになる。これを解消するためには、例えば、 R FIDリーダ 130のリーダアンテナ力も本体支持部材 114が充分に離反するように大き な凹所を形成することや、本体支持部材 114を高強度の榭脂で形成することが想定 できる (ともに図示せず)。しかし、これでは既存の薬液注入装置 100を大幅に改造す る必要がある。  However, in this case, the metal main body support member 114 is positioned in the vicinity of the reader antenna of the RFID reader 130, and the main body support member 114 hinders wireless communication between the RFID reader 130 and the RFID tag 230. Will be. In order to solve this problem, for example, the reader antenna force of the R FID reader 130 is also formed with a large recess so that the main body support member 114 is sufficiently separated, or the main body support member 114 is made of high-strength grease. It can be assumed to form (both not shown). However, this requires a major modification of the existing chemical injection device 100.
[0108] 本形態の薬液注入装置 100では、 RFIDリーダ 130をリーダアンテナが下側となる 状態で本体支持部材 114の下面に配置しているので、 RFIDリーダ 130の厚さにより リーダアンテナが本体支持部材 114の下面力 離反しており、金属製の本体支持部 材 114がリーダアンテナに影響することを防止できる。  In the chemical injection device 100 of this embodiment, since the RFID reader 130 is arranged on the lower surface of the main body support member 114 with the reader antenna on the lower side, the reader antenna is supported on the main body depending on the thickness of the RFID reader 130. The lower surface force of the member 114 is separated, and the metal main body support member 114 can be prevented from affecting the reader antenna.
[0109] ただし、これでは RFIDリーダ 130は金属製の本体支持部材 114の下側に位置し、However, in this case, the RFID reader 130 is positioned below the metal main body support member 114,
RFIDタグ 230は本体支持部材 114の上側に配置されるので、 RFIDタグ 230と RFISince the RFID tag 230 is disposed on the upper side of the main body support member 114, the RFID tag 230 and the RFI
Dリーダ 130とが直接に電磁結合することが困難である。 It is difficult for the D reader 130 to be directly electromagnetically coupled.
[0110] そこで、本形態の薬液注入装置 100では、アンテナシート 131の一端を本体支持 部材 114の上側で RFIDタグ 230と対向する位置に配置し、他端を本体支持部材 11Therefore, in the chemical injection device 100 of the present embodiment, one end of the antenna sheet 131 is arranged at a position facing the RFID tag 230 above the main body support member 114 and the other end is the main body support member 11.
4の下側で RFIDリーダ 130のリーダアンテナに密着させることにより、 RFIDリーダ 13RFID reader 13 by attaching it to the reader antenna of RFID reader 130 on the lower side of 4
0と RFIDタグ 230とを良好に電磁結合できるようにして 、る。 0 and the RFID tag 230 can be electromagnetically coupled well.
[0111] し力も、アンテナシート 131は RFIDタグ 230とともに量産されている既製品であり、 本体支持部材 114の改造はスリット状の貫通孔 133を形成するだけなので、本形態 の薬液注入装置 100は生産性が良好である。 [0111] However, the antenna sheet 131 is an off-the-shelf product that is mass-produced together with the RFID tag 230, and the modification of the main body support member 114 only forms the slit-shaped through hole 133. Productivity is good.
[0112] さらに、本形態の薬液注入装置 100では、 RFIDタグ 230と対向するアンテナシート 131の一端力 本体支持部材 114の表面にフェライトシート 135を介して配置されて いるので、アンテナシート 131より下側の電磁界はフェライトシート 135を通過すること になり、 RFIDタグ 230とアンテナシート 131との電磁結合が金属製の本体支持部材 114に阻害されることがな 、。 Furthermore, in the chemical injection device 100 of the present embodiment, the antenna sheet facing the RFID tag 230 One end force of 131 Since the ferrite sheet 135 is arranged on the surface of the main body support member 114, the electromagnetic field below the antenna sheet 131 passes through the ferrite sheet 135, and the RFID tag 230 and the antenna sheet 131 Electromagnetic coupling with the metal body support member 114 is not hindered.
[0113] なお、本形態の RFIDタグ 230のタグアンテナ 233は、細長形状のループアンテナ として形成されているので、その長手方向で湾曲されると通信性能が極端に低下す る。し力し、本形態の薬液シリンジ 200では、シリンダ部材 210と RFIDタグ 230との長 手方向が一致しているので、タグアンテナ 233は、短手方向で微少に湾曲されてい るだけで長手方向では湾曲されておらず、通信性能が良好である。  [0113] Note that the tag antenna 233 of the RFID tag 230 of the present embodiment is formed as an elongated loop antenna. Therefore, if the tag antenna 233 is bent in the longitudinal direction, the communication performance is extremely lowered. However, in the chemical syringe 200 of this embodiment, since the long direction of the cylinder member 210 and the RFID tag 230 are the same, the tag antenna 233 is simply bent slightly in the short direction, and the longitudinal direction. Is not curved and the communication performance is good.
[0114] さらに、 RFIDタグ 230は通信性能が液体によっても阻害される力 上述のように RF IDタグ 230はシリンダ部材 210に長手方向が一致する状態で装着する必要があるの で、シリンダ部材 210の薬液が充填されて!ヽな 、位置に RFIDタグ 230を配置するこ とは困難である。  [0114] Further, the RFID tag 230 is a force whose communication performance is hindered even by liquid. As described above, the RF ID tag 230 needs to be attached to the cylinder member 210 in a state in which the longitudinal direction coincides with the cylinder member 210. It is difficult to place the RFID tag 230 at a position that is filled with the chemical solution.
[0115] し力し、本形態の薬液シリンジ 200は、シリンダ部材 210力 Sl.5mm〜2.0mm程度と充 分な肉厚に形成されているので、その表面に貼付された RFIDタグ 230はシリンダ部 材 210に充填されている薬液に阻害されることなく良好に無線通信することができる  [0115] Since the drug solution syringe 200 of this embodiment is formed with a sufficient thickness such as the cylinder member 210 force Sl. 5 mm to 2.0 mm, the RFID tag 230 attached to the surface of the syringe 200 is a cylinder. Wireless communication can be satisfactorily performed without being hindered by the chemical solution filled in the part 210.
[0116] [実施の形態の変形例] [0116] [Modification of Embodiment]
本発明は上記形態に限定されるものではなぐその要旨を逸脱しない範囲で各種 の変形を許容する。例えば、上記形態では注入ヘッド 110に薬液シリンジ 200が 1個 のみ装着される薬液注入装置 100を例示したが、図 13に示すように、注入ヘッド 17 0に複数の薬液シリンジ 200が装着される薬液注入装置 (図示せず)も実施可能であ る。  The present invention is not limited to the above embodiment, and various modifications are allowed without departing from the spirit of the present invention. For example, in the above embodiment, the chemical injection device 100 in which only one chemical syringe 200 is attached to the injection head 110 is illustrated, but as shown in FIG. 13, the chemical solution in which a plurality of chemical syringes 200 are attached to the injection head 170 An injection device (not shown) can also be implemented.
[0117] また、上記形態では RFIDタグ 230から RFIDリーダ 130により検出された記録デー タが、注入ヘッド 110とは別体の注入制御ュ-ット 101の液晶ディスプレイ 104に表 示されることを例示した。しかし、図 13に示すように、注入ヘッド 170に液晶ディスプ レイなどのディスプレイデバイス 171を搭載しておき、そこに RFIDタグ 230の記録デ ータを表示することも可能である。 [0118] この場合、注入ヘッド 170に薬液シリンジ 200が適切に装着されると、その注入へッ ド 170のディスプレイデバイス 171に記録データが表示されるので、作業者は薬液シ リンジ 200が適切に装着されたかを迅速に確認することができ、表示データを直感的 に認識することができる。 [0117] Further, in the above embodiment, the recording data detected by the RFID reader 130 from the RFID tag 230 is displayed on the liquid crystal display 104 of the injection control unit 101 separate from the injection head 110. did. However, as shown in FIG. 13, it is possible to mount a display device 171 such as a liquid crystal display on the injection head 170 and display the recorded data of the RFID tag 230 there. [0118] In this case, when the chemical syringe 200 is properly attached to the injection head 170, the recorded data is displayed on the display device 171 of the injection head 170, so that the operator can properly use the chemical syringe 200. It is possible to quickly check whether it is installed and to recognize the display data intuitively.
[0119] さらに、上記形態では左右一対のフランジ保持部材 121の固定保持部材 122が可 動保持部材 123とともに左右に分離されていることを例示した力 例えば、左右の固 定保持部材が下方で一体に連結されていて可動保持部材 123のみが左右に分離さ れていることも可能である (図示せず)。あるいは、図 13に示すように、フランジ保持部 材が可動しない固定保持部材 173のみで本体保持部材 174と一体に形成されてい ることち可會である。  [0119] Further, in the above embodiment, a force exemplifying that the fixed holding member 122 of the pair of left and right flange holding members 121 is separated into the left and right together with the movable holding member 123. For example, the left and right fixed holding members are integrally formed below. It is also possible that only the movable holding member 123 is separated to the left and right (not shown). Alternatively, as shown in FIG. 13, it is possible that the flange holding member is formed integrally with the main body holding member 174 only by the fixed holding member 173 that does not move.
[0120] また、例えば、固定保持部材の保持スリットの前面および後面の少なくとも一方に凸 部を形成しておき、その凸部をシリンダフランジの前面および後面の少なくとも一方 の下部のみに形成した凹部に係合させることも可能である (図示せず)。この場合、シ リンダフランジの平坦部が上下に位置する状態でも、薬液シリンジが逆様の状態で薬 液注入装置に装着されることがない。  [0120] Further, for example, a convex portion is formed on at least one of the front surface and the rear surface of the holding slit of the fixed holding member, and the convex portion is formed on a concave portion formed only on at least one lower portion of the front surface and the rear surface of the cylinder flange. It is also possible to engage (not shown). In this case, even when the flat portion of the cylinder flange is positioned up and down, the chemical syringe is not attached to the chemical injection device in the opposite state.
[0121] さらに、上記形態では薬液シリンジ 200の下面に RFIDタグ 230が装着されているこ とのみ例示したが、例えば、透明な薬液が充填されているシリンダ部材 210を介して 上方力も視認されると所定の形状となる図柄が、シリンダ部材 210の下面と本体保持 部材 114の保持凹部 115の内面とに分割されて表記されて 、ることも可能である (図 示せず)。この場合、薬液シリンジが適切に保持されているかを、 RFIDリーダ 130と 上述の図柄との両方で確認することができ、さらに、シリンダ部材 210に薬液が充填 されている力も図柄で確認することができる。  Furthermore, in the above embodiment, only the RFID tag 230 is attached to the lower surface of the chemical syringe 200. However, for example, the upward force is also visually recognized through the cylinder member 210 filled with a transparent chemical solution. It is also possible that the symbol having a predetermined shape is divided into the lower surface of the cylinder member 210 and the inner surface of the holding recess 115 of the main body holding member 114 (not shown). In this case, whether or not the chemical syringe is properly held can be confirmed by both the RFID reader 130 and the above-described design, and the force with which the cylinder member 210 is filled with the chemical solution can also be confirmed by the design. it can.
[0122] また、上記形態では RFIDタグ 230がシリンダ部材 210に長手方向が一致する状態 で装着されていることを例示した。しかし、例えば、シリンダ部材 210の外周面に RFI Dタグ 230が長手方向で卷回されるように装着されて!、ることも可能である (図示せず)  [0122] In the above embodiment, the RFID tag 230 is mounted on the cylinder member 210 in a state in which the longitudinal direction coincides. However, for example, the RFI D tag 230 can be mounted on the outer peripheral surface of the cylinder member 210 so as to be wound in the longitudinal direction! (Not shown)
[0123] さらに、上記形態では RFIDタグ 230の電磁誘導を薬液が阻害しない肉厚にシリン ダ部材 210の全体が形成されていることを例示した力 例えば、シリンダ部材の肉厚 が充分ではない場合、 RFIDタグ 230が装着される部分のみを所定の肉厚に形成し ておくことも可能であり、榭脂の台座などを介して RFIDタグ 230をシリンダ部材に装 着することも可能である (ともに図示せず)。 [0123] Further, in the above embodiment, the force exemplifying that the entire cylinder member 210 is formed with a thickness that does not inhibit the electromagnetic induction of the RFID tag 230. For example, the thickness of the cylinder member If this is not sufficient, it is possible to form only the part where the RFID tag 230 is attached to a predetermined thickness, and attach the RFID tag 230 to the cylinder member via a pedestal of grease, etc. Is possible (both not shown).
[0124] また、フェライトなどの高透磁率な強磁性体を RFIDタグ 230と同等な形状のシート 状に形成し、この磁性体を介してシリンダ部材 210の外周面に RFIDタグ 230を配置 することも可能である (図示せず)。この場合、 RFIDタグ 230の裏側の電磁界が磁性 体を通過するので、その電磁界が薬液に吸収されることを防止でき、 RFIDタグ 230 の通信性能を向上させることができる。  [0124] Further, a ferromagnetic material such as ferrite having a high magnetic permeability is formed in a sheet shape having the same shape as that of the RFID tag 230, and the RFID tag 230 is disposed on the outer peripheral surface of the cylinder member 210 via the magnetic material. Is also possible (not shown). In this case, since the electromagnetic field on the back side of the RFID tag 230 passes through the magnetic material, the electromagnetic field can be prevented from being absorbed by the chemical solution, and the communication performance of the RFID tag 230 can be improved.
[0125] さらに、上記形態では本体支持部材 114の貫通孔 133に挿通されたアンテナシー ト 131の一端である上部が後方に曲折されて RFIDタグ 230と対向する位置に配置さ れているとともに、他端である下部が前方に曲折されて RFIDリーダ 130に密着され ていることを例示した。  [0125] Furthermore, in the above embodiment, the upper part, which is one end of the antenna sheet 131 inserted through the through hole 133 of the main body support member 114, is bent rearward and disposed at a position facing the RFID tag 230. The lower end, which is the other end, is bent forward and is shown in close contact with the RFID reader 130.
[0126] しかし、 RFIDリーダ 130が貫通孔 133の後方に配置されており、アンテナシート 13 1の下部が後方に曲折されて RFIDリーダ 130に密着されていることも可能であり、ァ ンテナシート 131の上部が前方に曲折されて RFIDタグ 230と対向することも可能で ある (ともに図示せず)。  However, the RFID reader 130 is disposed behind the through-hole 133, and the lower portion of the antenna sheet 131 can be bent rearward to be in close contact with the RFID reader 130. It is also possible that the upper part of the PC is bent forward so as to face the RFID tag 230 (both not shown).
[0127] また、上記形態では薬液注入装置 100の本体保持部材 114の下部に貫通孔 133 が形成されているとともにアンテナシート 131や RFIDリーダ 130が配置されており、 薬液シリンジ 200のシリンダ部材 210の下部に RFIDタグ 230が配置されていることを 例示した。  [0127] Further, in the above embodiment, the through hole 133 is formed in the lower part of the main body holding member 114 of the chemical liquid injector 100, and the antenna sheet 131 and the RFID reader 130 are arranged. The RFID tag 230 is placed at the bottom.
[0128] しかし、本体保持部材 114の左部や右部などに貫通孔 133が形成されているととも にアンテナシート 131や RFIDリーダ 130が配置されており、それに対応するシリンダ 部材 210の左部や右部などに RFIDタグ 230が配置されていることも可能である (図 示せず)。  However, through holes 133 are formed in the left and right parts of the main body holding member 114 and the antenna sheet 131 and the RFID reader 130 are arranged, and the corresponding left part of the cylinder member 210 is arranged. It is also possible that the RFID tag 230 is arranged on the right side or the like (not shown).
[0129] さらに、上記形態では厚さを無視できる程度のフェライトシート 135およびアンテナ シート 131が本体保持部材 114の保持凹部 115の底面に配置されて ヽることを例示 したが、例えば、保持凹部 115の底面に凹穴を形成してフェライトシート 135およびァ ンテナシート 131の一端を配置することも可能である (図示せず)。この場合、フェライト シート 135およびアンテナシート 131の厚さを無視できないようなときでも、その厚さ に阻害されることなく保持凹部 115に薬液シリンジ 200を良好に装着することができる Furthermore, in the above embodiment, the ferrite sheet 135 and the antenna sheet 131 having negligible thicknesses are arranged on the bottom surface of the holding recess 115 of the main body holding member 114, but for example, the holding recess 115 One end of the ferrite sheet 135 and the antenna sheet 131 can also be disposed by forming a concave hole in the bottom surface (not shown). In this case, ferrite Even when the thickness of the sheet 135 and the antenna sheet 131 cannot be ignored, the chemical syringe 200 can be satisfactorily attached to the holding recess 115 without being obstructed by the thickness.
[0130] また、上記形態ではアンテナシート 131の他端上面が RFIDリーダ 130の下面に密 着されていることを例示したが、電磁誘導が良好に実行される範囲ならば、アンテナ シート 131の他端上面と RFIDリーダ 130の下面とが離反して対向していることも可能 である (図示せず)。 [0130] In the above embodiment, the upper surface of the other end of the antenna sheet 131 is illustrated as being closely attached to the lower surface of the RFID reader 130. However, as long as electromagnetic induction is performed satisfactorily, the antenna sheet 131 It is also possible for the upper surface of the end and the lower surface of the RFID reader 130 to face each other apart (not shown).
[0131] さらに、上記形態では説明を簡単にするため、薬液注入装置 100に装着される薬 液シリンジ 200のサイズが 1つであることを想定した。しかし、本出願人が実施してい る薬液注入システムでは、薬液シリンジ 200に複数種類のサイズがあり、図 14に示す ように、最大以外のサイズの薬液シリンジ 200ごとにシリンダアダプタ 400が用意され ている。  [0131] Further, in the above embodiment, for simplification of description, it is assumed that the size of the chemical syringe 200 attached to the chemical injection device 100 is one. However, in the chemical injection system implemented by the present applicant, the chemical syringe 200 has a plurality of sizes, and as shown in FIG. 14, a cylinder adapter 400 is prepared for each chemical syringe 200 of a size other than the maximum. Yes.
[0132] このような薬液注入システムでは、最大サイズの薬液シリンジ 200は薬液注入装置 100に直接装着され、最大以外のサイズの薬液シリンジ 200はシリンダアダプタ 400 を介して装着される。そこで、薬液注入装置 100にシリンダアダプタ 400が適切に装 着されたとき、アンテナシート 131の一端と平行に対向するシリンダアダプタ 400の外 面や内面にも、 RFIDタグ 230を装着しておくことが可能である。  In such a chemical solution injection system, the chemical solution syringe 200 having the maximum size is directly attached to the chemical solution injection device 100, and the chemical solution syringe 200 having a size other than the maximum size is attached via the cylinder adapter 400. Therefore, when the cylinder adapter 400 is properly attached to the chemical injection device 100, the RFID tag 230 may be attached to the outer surface or inner surface of the cylinder adapter 400 that faces the one end of the antenna sheet 131 in parallel. Is possible.
[0133] この場合、薬液注入装置 100は、シリンダアダプタ 400と薬液シリンジ 200との両方 が適切に装着されているかを確認することができる。そして、シリンダアダプタ 400の 記録データと薬液シリンジ 200の記録データとを照合することにより、その薬液シリン ジ 200とシリンダアダプタ 400との組み合わせが適切かを確認するようなこともできる  [0133] In this case, the chemical liquid injector 100 can check whether both the cylinder adapter 400 and the chemical syringe 200 are properly attached. Then, by comparing the recorded data of the cylinder adapter 400 with the recorded data of the chemical syringe 200, it can be confirmed that the combination of the chemical syringe 200 and the cylinder adapter 400 is appropriate.
[0134] し力も、 MMタグ用の RFIDリーダ 130などは複数の RFIDタグ 230と無線通信でき るので、薬液注入装置 100は、 1個の RFIDリーダ 130でシリンダアダプタ 400と薬液 シリンジ 200との両方の RFIDタグ 230と無線通信することができる。 [0134] Since the RFID reader 130 for the MM tag can wirelessly communicate with a plurality of RFID tags 230, the chemical injection device 100 can use both the cylinder adapter 400 and the chemical syringe 200 with one RFID reader 130. Wireless communication with RFID tag 230.
[0135] なお、上述のような薬液注入システムでは、薬液シリンジ 200の RFIDタグ 230と薬 液注入装置 100のアンテナシート 131とがシリンダアダプタ 400を介して対向すること になるので、このシリンダアダプタ 400は RFIDタグ 230と RFIDリーダ 130との無線 通信を阻害しない榭脂などの非磁性体で形成しておくことが好適である。 In the chemical solution injection system as described above, the RFID tag 230 of the chemical solution syringe 200 and the antenna sheet 131 of the chemical solution injection device 100 face each other via the cylinder adapter 400. Radio between RFID tag 230 and RFID reader 130 It is preferable to form with a non-magnetic material such as rosin that does not hinder communication.
[0136] また、上記形態では薬液シリンジ 200などの使用を一度に制限するため、使用され る薬液シリンジ 200の RFIDタグ 230から個体ごとの製造番号を薬液注入装置 100が RFIDリーダ 130で無線受信して記憶し、新規に無線受信された製造番号が記憶さ れていると確認警告を出力することを例示した。  [0136] Further, in the above embodiment, since the use of the chemical syringe 200 and the like is restricted at a time, the chemical injection device 100 wirelessly receives the manufacturing number for each individual from the RFID tag 230 of the chemical syringe 200 used by the RFID reader 130. This example illustrates that a confirmation warning is output when a new serially received serial number is stored.
[0137] しかし、薬液シリンジ 200の RFIDタグ 230をデータ追記が可能な製品としておき、 薬液注入装置 100が、装着されて注入動作が実行された薬液シリンジ 200の RFID タグ 230に使用済を記録し、新規の薬液シリンジ 200の RFIDタグ 230から使用済が 無線受信されると確認警告を出力することも可能である。  [0137] However, the RFID tag 230 of the chemical syringe 200 is set as a product in which data can be added, and the chemical injection device 100 records the used state in the RFID tag 230 of the chemical syringe 200 that is installed and the injection operation is executed. It is also possible to output a confirmation warning when used is received wirelessly from the RFID tag 230 of the new chemical syringe 200.
[0138] この場合、薬液注入装置 100に膨大な製造番号を登録しておく必要がないので、 RAM143のオーバーフローなどを防止することができ、無用に大容量な RAM143 などを搭載する必要もない。し力も、薬液注入装置 100の記憶データが不正にリセッ トされても、薬液シリンジ 200の不正な繰り返し利用を防止することができる。  In this case, since it is not necessary to register an enormous number of manufacturing numbers in the chemical injection device 100, overflow of the RAM 143 can be prevented, and there is no need to install an unnecessarily large capacity RAM 143 or the like. Even if the stored data of the chemical injection device 100 is illegally reset, illegal repeated use of the chemical syringe 200 can be prevented.
[0139] さらに、上記形態では薬液シリンジ 200の RFIDタグ 230から薬液注入装置 100に 薬液注入の制御データなども無線受信され、その制御データに対応して薬液注入装 置 100が薬液注入動作を制御することのみを例示した。しかし、薬液注入装置 100 が薬液シリンジ 200の RFIDタグ 230から無線受信する制御データと、操作パネル 10 3などから入力操作される制御データと、の組み合わせに対応して薬液注入動作を 制御することも可能である。  [0139] Furthermore, in the above embodiment, chemical solution injection control data and the like are also received wirelessly from the RFID tag 230 of the chemical syringe 200 to the chemical injection device 100, and the chemical injection device 100 controls the chemical injection operation according to the control data. Exemplified only to do. However, the chemical injection device 100 may control the chemical injection operation corresponding to a combination of control data received wirelessly from the RFID tag 230 of the chemical syringe 200 and control data input from the operation panel 103 or the like. Is possible.
[0140] 例えば、前述のように薬液シリンジ 200の RFIDタグ 230に薬液注入の経時的な可 変パターンを記録しておき、 CTスキャナ 300による撮像部位が操作パネル 103など に入力操作されると、その撮像部位に対応して可変パターンが調整されるようなこと も可能である。  [0140] For example, as described above, a time-varying pattern of chemical injection is recorded in the RFID tag 230 of the chemical syringe 200, and when an imaging region by the CT scanner 300 is input to the operation panel 103 or the like, It is also possible to adjust the variable pattern corresponding to the imaging region.
[0141] また、上記形態では注入動作を終了して薬液シリンジ 200の RFIDタグ 230から無 線受信した製造番号を登録した薬液注入装置 100が各種動作を終了することを想 定した。しかし、例えば、上述のように注入動作と製造番号のデータ登録とを完了し た薬液注入装置 100が、 RFIDリーダ 130により薬液シリンジ 200の取り外しを検出 すると、ピストン駆動機構 116を最後尾の初期位置まで自動的に後退させることも可 能である。 [0141] Also, in the above embodiment, it is assumed that the chemical injection device 100 that has registered the serial number received wirelessly from the RFID tag 230 of the chemical syringe 200 after completing the injection operation ends various operations. However, for example, when the chemical injection device 100 that has completed the injection operation and registration of the serial number data as described above detects the removal of the chemical syringe 200 by the RFID reader 130, the piston drive mechanism 116 is moved to the initial position at the end. Can be automatically retracted Noh.
[0142] さらに、このように各種動作を完了してピストン駆動機構 116を初期位置まで後退さ せた薬液注入装置 100が、 RFIDリーダ 130により新規の薬液シリンジ 200の装着を 検出すると、ピストン部材 210を保持する準備位置までピストン駆動機構 116を自動 的に前進させることも可能である。  [0142] Further, when the chemical injection device 100 that completes various operations in this way and retracts the piston drive mechanism 116 to the initial position detects the attachment of the new chemical syringe 200 by the RFID reader 130, the piston member 210 It is also possible to automatically advance the piston drive mechanism 116 to a preparation position for holding the valve.
[0143] これらの場合、薬液シリンジ 200が適切なタイミングで薬液注入装置 100に着脱さ れることでピストン駆動機構 116が自動的に適切な位置に配置されるので、この配置 に特別な操作は必要なぐ薬液注入装置 100の利便性をさらに向上させることができ る。  [0143] In these cases, the piston drive mechanism 116 is automatically arranged at an appropriate position by attaching / detaching the chemical syringe 200 to / from the chemical injection device 100 at an appropriate timing. The convenience of the chemical injection device 100 can be further improved.
[0144] また、上記形態では薬液シリンジ 200の RFIDタグ 230に製造メーカが各種データ を記録しておくことを想定した力 例えば、薬液シリンジ 200などを使用する病院など の医療現場で薬液シリンジ 200の RFIDタグ 230に各種データを記録することも可能 である。  [0144] Further, in the above embodiment, the force that the manufacturer assumes to record various data in the RFID tag 230 of the chemical syringe 200. For example, the medical syringe 200 is used in a medical site such as a hospital where the chemical syringe 200 is used. Various data can be recorded on the RFID tag 230.
[0145] この場合、医療現場で薬液シリンジ 200に所望のデータを付与することができるの で、例えば、リフィルタイプの薬液シリンジ 200に所望の薬液を充填するとき、その薬 液の各種データを RFIDタグ 230で記録するようなことが可能となる。このような場合 でも、例えば、前述のように薬液シリンジ 200の繰り返し利用を防止するための製造 番号などは、 RFIDタグ 230に事前に固定的に記録しておくことが好適である。  [0145] In this case, since desired data can be given to the chemical syringe 200 at the medical site, for example, when filling the desired chemical liquid into the refill type chemical syringe 200, various data of the chemical solution are RFIDd. Recording with tag 230 is possible. Even in such a case, for example, as described above, it is preferable that the manufacturing number for preventing the chemical syringe 200 to be repeatedly used is recorded in advance in the RFID tag 230 in a fixed manner.
[0146] さらに、上記形態では薬液注入装置 100が被験者に薬液を注入するために、薬液 シリンジ 200のシリンダ部材 210にピストン部材 220を押し込むことのみ例示したが、 例えば、別体の薬液パックを延長チューブで連結したシリンダ部材 210からピストン 部材 220を引き出すことにより、薬液注入装置 100が薬液シリンジ 200に薬液を充填 することも可能である (図示せず)。  [0146] Furthermore, in the above embodiment, only the piston member 220 is pushed into the cylinder member 210 of the drug solution syringe 200 in order for the drug solution injection device 100 to inject the drug solution into the subject. However, for example, a separate drug solution pack is extended. By extracting the piston member 220 from the cylinder member 210 connected by a tube, the chemical solution injection device 100 can also fill the chemical solution syringe 200 with the chemical solution (not shown).
[0147] また、上記形態では透視撮像装置として CTスキャナ 300を使用し、薬液注入装置 100が CT用の造影剤を注入することを例示したが、例えば、透視撮像装置として M RI装置や PET装置などを使用し、それ用の造影剤を薬液注入装置が注入することも 可能である。  [0147] In the above embodiment, the CT scanner 300 is used as the fluoroscopic imaging apparatus, and the chemical injection device 100 injects the contrast medium for CT. For example, the MRI apparatus and the PET apparatus are used as the fluoroscopic imaging apparatus. It is also possible to inject a contrast medium for the same using a chemical injection device.
[0148] さらに、上記形態では薬液注入装置 100などの各部を具体的に説明したが、その 各部も各種に変更可能であり、例えば、ピストン駆動機構の駆動源が DC(Direct Cur rent)モータや超音波モータやリニアモータやソレノイドで形成されて!、ること、デイス プレイデバイスが EL(Electro- Luminescence)ディスプレイやプラズマディスプレイで形 成されていること、等も可能である (図示せず)。 [0148] Furthermore, in the above embodiment, each part such as the chemical liquid injector 100 has been specifically described. Each part can be changed in various ways.For example, the drive source of the piston drive mechanism is formed by a direct current (DC) motor, ultrasonic motor, linear motor or solenoid! -Luminescence) It can also be formed with a display or plasma display (not shown).
また、上記形態では RAM143等に格納されているコンピュータプログラムに対応し て CPU141が動作することにより、薬液注入装置 100の各種機能として各種手段が 論理的に実現されることを例示した。しかし、このような各種手段の各々を固有のハ 一ドウエアとして形成することも可能であり、一部をソフトウェアとして RAM143等に 格納するとともに一部をノヽードウエアとして形成することも可能である。  In the above embodiment, the CPU 141 is operated corresponding to the computer program stored in the RAM 143 and the like, and various means are logically realized as various functions of the chemical solution injector 100. However, each of these various means can be formed as unique hardware, and a part can be stored in the RAM 143 as software and a part can be formed as node hardware.

Claims

請求の範囲 The scope of the claims
[1] シリンダ本体の後端外周にシリンダフランジが形成されて ヽるシリンダ部材にピスト ン部材がスライド自在に挿入されて!、る薬液シリンジと、前記薬液シリンジの前記シリ ンダ部材に前記ピストン部材を押し込んで被験者に薬液を注入する薬液注入装置と 、を有している薬液注入システムであって、  [1] A cylinder flange is formed on the outer periphery of the rear end of the cylinder body, and a piston member is slidably inserted into a cylinder member. The piston member is inserted into the cylinder member of the drug syringe and the cylinder member of the drug syringe. A chemical injection device for injecting a chemical into a subject by pushing
前記薬液シリンジには、記録データを電磁誘導により無線送信する RFID(Radio Fr equency Identification)タグが前記シリンダ本体の外周面上の所定位置に装着されて おり、  An RFID (Radio Frequency Identification) tag that wirelessly transmits recorded data by electromagnetic induction is attached to the chemical syringe at a predetermined position on the outer peripheral surface of the cylinder body,
前記薬液注入装置は、上方カゝら挿入される前記シリンダ本体を保持する保持凹部 が設けられた金属製の本体保持部材と、前記本体保持部材に支持されて 、て上方 力 挿入される前記シリンダフランジを保持する金属製のフランジ保持部材と、前記 シリンダフランジとともに保持された前記シリンダ本体に前記ピストン部材を押し込む ピストン駆動機構と、前記 RFIDタグの記録データを電磁誘導により無線受信する RF IDリーダと、前記記録データの無線受信に対応して前記ピストン駆動機構の動作を 制御する動作制御手段と、細長形状のループアンテナを有するアンテナシートと、を 有しており、  The chemical injection device includes a metal main body holding member provided with a holding recess for holding the cylinder main body to be inserted from the upper side, and the cylinder inserted by an upper force supported by the main body holding member. A metal flange holding member that holds the flange, a piston drive mechanism that pushes the piston member into the cylinder body held together with the cylinder flange, and an RF ID reader that wirelessly receives the recording data of the RFID tag by electromagnetic induction; And an operation control means for controlling the operation of the piston drive mechanism in response to wireless reception of the recording data, and an antenna sheet having an elongated loop antenna,
前記本体保持部材には前記保持凹部の外面から内面まで貫通する貫通孔が形成 され、前記 RFIDリーダは前記保持凹部の外面の前記貫通孔に隣接した位置に配置 され、かつ前記貫通孔に揷通されている前記アンテナシートは、一端が前記保持凹 部の内面に配置されているとともに他端が前記 RFIDリーダに対向している薬液注入 システム。  The main body holding member is formed with a through-hole penetrating from the outer surface to the inner surface of the holding recess, and the RFID reader is disposed at a position adjacent to the through-hole on the outer surface of the holding recess, and penetrates the through-hole. The antenna sheet is configured such that one end is disposed on the inner surface of the holding recess and the other end faces the RFID reader.
[2] 前記 RFIDタグは、略長方形のシート状に形成されており、  [2] The RFID tag is formed in a substantially rectangular sheet shape,
前記アンテナシートは、略長方形のシートにループアンテナが形成された構造を有 して 、る請求項 1に記載の薬液注入システム。  2. The chemical solution injection system according to claim 1, wherein the antenna sheet has a structure in which a loop antenna is formed on a substantially rectangular sheet.
[3] 前記 RFIDタグは、特定の回転位置で前記本体保持部材に保持された前記シリン ダ部材の下方の位置に配置されており、 [3] The RFID tag is disposed at a position below the cylinder member held by the main body holding member at a specific rotational position,
前記保持凹部の底面に前記アンテナシートの一端が配置されている請求項 1また は 2に記載の薬液注入システム。 The chemical injection system according to claim 1 or 2, wherein one end of the antenna sheet is disposed on a bottom surface of the holding recess.
[4] 前記本体保持部材は非磁性の金属で形成されており、前記アンテナシートの一端 がシート状の磁性体を介して前記保持凹部の内面に配置されている請求項 1ないし[4] The main body holding member is made of a nonmagnetic metal, and one end of the antenna sheet is disposed on the inner surface of the holding recess via a sheet-like magnetic body.
3の何れか一項に記載の薬液注入システム。 4. The chemical injection system according to any one of 3.
[5] 前記 RFIDタグは、前記シリンダ本体の外周面にシート状の磁性体を介して配置さ れて 、る請求項 1な 、し 4の何れか一項に記載の薬液注入システム。 [5] The chemical injection system according to any one of [1] to [4], wherein the RFID tag is disposed on an outer peripheral surface of the cylinder body via a sheet-like magnetic body.
[6] 前記磁性体はフェライトである請求項 4または 5に記載の薬液注入システム。 6. The chemical injection system according to claim 4 or 5, wherein the magnetic body is ferrite.
[7] 透明な薬液が充填されている前記シリンダ部材を介して上方力 視認されると所定 の形状となる図柄が、前記シリンダ部材の下面と前記保持凹部の内面とに分割され て表記されて 、る請求項 1な 、し 6の何れか一項に記載の薬液注入システム。 [7] A pattern that has a predetermined shape when an upward force is visually recognized through the cylinder member filled with a transparent chemical solution is divided into a lower surface of the cylinder member and an inner surface of the holding recess. The chemical injection system according to any one of claims 1 and 6.
[8] 前記フランジ保持部材は、上方力も挿入される前記薬液シリンジのシリンダフランジ を前後から保持する、前面および後面の少なくとも一方に凸部が形成された保持スリ ットを有し、 [8] The flange holding member has a holding slit having a convex portion formed on at least one of the front and rear surfaces for holding the cylinder flange of the chemical syringe into which the upward force is also inserted from the front and rear.
前記シリンダフランジの前面および後面の少なくとも一方に、特定の回転位置で前 記凸部が係合する凹部が形成されている請求項 1ないし 7の何れか一項に記載の薬 液注入システム。  The chemical injection system according to any one of claims 1 to 7, wherein a concave portion that engages with the convex portion at a specific rotational position is formed on at least one of a front surface and a rear surface of the cylinder flange.
[9] 前記動作制御手段は、前記薬液シリンジの RFIDタグを前記 RFIDリーダが検出し て 、るときのみ、前記ピストン駆動機構の動作を許可する請求項 1な 、し 8の何れか 一項に記載の薬液注入システム。  [9] The operation control means permits the operation of the piston drive mechanism only when the RFID reader detects and detects the RFID tag of the chemical syringe. The chemical solution injection system described.
[10] シリンダ本体の後端外周にシリンダフランジが形成されて ヽるシリンダ部材にピスト ン部材力 Sスライド自在に挿入され、記録データを電磁誘導により無線送信する RFID( Radio Frequency Identification)タグが前記シリンダ本体の外周面上の所定位置に装 着されて!、る薬液シリンジが装着され、前記シリンダ部材に前記ピストン部材を押し 込んで被験者に薬液を注入する薬液注入装置であって、  [10] A cylinder flange is formed on the outer periphery of the rear end of the cylinder body, and a piston member force S is slidably inserted into a cylinder member, and an RFID (Radio Frequency Identification) tag that wirelessly transmits recording data by electromagnetic induction A chemical injection device that is mounted at a predetermined position on the outer peripheral surface of the cylinder body, and is equipped with a chemical syringe, and pushes the piston member into the cylinder member to inject the chemical into a subject,
上方カゝら挿入される前記シリンダ本体を保持する保持凹部が設けられたる金属製 の本体保持部材と、  A metal main body holding member provided with a holding recess for holding the cylinder main body inserted from above;
前記本体保持部材に支持されていて上方カゝら挿入される前記シリンダフランジを保 持する金属製のフランジ保持部材と、  A metal flange holding member that is supported by the main body holding member and holds the cylinder flange that is inserted into the upper cover;
前記シリンダフランジとともに保持された前記シリンダ本体に前記ピストン部材を押 し込むピストン駆動機構と、 The piston member is pressed against the cylinder body held together with the cylinder flange. A piston drive mechanism to be inserted;
前記 RFIDタグの記録データを電磁誘導により無線受信する RFIDリーダと、 前記記録データの無線受信に対応して前記ピストン駆動機構の動作を制御する動 作制御手段と、  An RFID reader that wirelessly receives the recording data of the RFID tag by electromagnetic induction; and an operation control means that controls the operation of the piston drive mechanism in response to the wireless reception of the recording data;
細長形状のループアンテナを有するアンテナシートと、を有しており、  An antenna sheet having an elongated loop antenna,
前記本体保持部材には前記保持凹部の外面から内面まで貫通する貫通孔が形成 され、  The main body holding member is formed with a through hole penetrating from the outer surface to the inner surface of the holding recess,
前記 RFIDリーダは前記保持凹部の外面の前記貫通孔に隣接した位置に配置され  The RFID reader is disposed at a position adjacent to the through hole on the outer surface of the holding recess.
前記貫通孔に揷通されている前記アンテナシートは、一端が前記保持凹部の内面 に配置されているとともに他端が前記 RFIDリーダに対向している薬液注入装置。 前記 RFIDタグは、略長方形のシート状に形成されており、 The antenna sheet passed through the through hole is a chemical solution injector in which one end is disposed on the inner surface of the holding recess and the other end faces the RFID reader. The RFID tag is formed in a substantially rectangular sheet shape,
前記アンテナシートは、略長方形のシートにループアンテナが形成された構造を有 して ヽる請求項 10に記載の薬液注入装置。  11. The chemical solution injector according to claim 10, wherein the antenna sheet has a structure in which a loop antenna is formed on a substantially rectangular sheet.
PCT/JP2007/057411 2006-04-05 2007-04-02 Medicinal-liquid injection system WO2007116863A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008509836A JP5063591B2 (en) 2006-04-05 2007-04-02 Chemical injection system

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006104620 2006-04-05
JP2006-104620 2006-04-05

Publications (1)

Publication Number Publication Date
WO2007116863A1 true WO2007116863A1 (en) 2007-10-18

Family

ID=38581153

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2007/057411 WO2007116863A1 (en) 2006-04-05 2007-04-02 Medicinal-liquid injection system

Country Status (2)

Country Link
JP (1) JP5063591B2 (en)
WO (1) WO2007116863A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012510868A (en) * 2008-12-05 2012-05-17 マリンクロッド エルエルシー Inductively coupled injector faceplate
JP2021506476A (en) * 2017-12-21 2021-02-22 サノフイSanofi Transmission of data related to the use of injection devices using passive RF modulation
EP3777924A4 (en) * 2018-03-29 2022-05-04 TERUMO Kabushiki Kaisha Pre-filled syringe, liquid medicine administration system, and syringe pump

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1288394A4 (en) * 2000-05-15 2005-01-05 Kensuke Asakura Method and device for removing part of concrete structure

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08509402A (en) * 1993-05-04 1996-10-08 ゼネカ・リミテッド Syringe and syringe pump
JPH10162260A (en) * 1996-11-29 1998-06-19 Mitsubishi Materials Corp Tag for robbery prevention
WO2003024385A1 (en) * 2001-09-12 2003-03-27 Terumo Kabushiki Kaisha Medicine container and medicine injector comprising the same
JP2004187849A (en) * 2002-12-10 2004-07-08 Nemoto Kyorindo:Kk Medical solution feeder
WO2005097232A1 (en) * 2004-04-05 2005-10-20 Nemoto Kyorindo Co., Ltd Medical liquid injection system
JP2006034719A (en) * 2004-07-28 2006-02-09 Terumo Corp Syringe pump, and transfusion method by syringe pump

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08509402A (en) * 1993-05-04 1996-10-08 ゼネカ・リミテッド Syringe and syringe pump
JPH10162260A (en) * 1996-11-29 1998-06-19 Mitsubishi Materials Corp Tag for robbery prevention
WO2003024385A1 (en) * 2001-09-12 2003-03-27 Terumo Kabushiki Kaisha Medicine container and medicine injector comprising the same
JP2004187849A (en) * 2002-12-10 2004-07-08 Nemoto Kyorindo:Kk Medical solution feeder
WO2005097232A1 (en) * 2004-04-05 2005-10-20 Nemoto Kyorindo Co., Ltd Medical liquid injection system
JP2006034719A (en) * 2004-07-28 2006-02-09 Terumo Corp Syringe pump, and transfusion method by syringe pump

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012510868A (en) * 2008-12-05 2012-05-17 マリンクロッド エルエルシー Inductively coupled injector faceplate
JP2021506476A (en) * 2017-12-21 2021-02-22 サノフイSanofi Transmission of data related to the use of injection devices using passive RF modulation
JP7328224B2 (en) 2017-12-21 2023-08-16 サノフイ Transmission of data related to use of injection devices using passive RF modulation
US11769578B2 (en) 2017-12-21 2023-09-26 Sanofi Transmission of data associated with an injection device usage using passive RF modulation
EP3777924A4 (en) * 2018-03-29 2022-05-04 TERUMO Kabushiki Kaisha Pre-filled syringe, liquid medicine administration system, and syringe pump
JP7412330B2 (en) 2018-03-29 2024-01-12 テルモ株式会社 syringe pump

Also Published As

Publication number Publication date
JP5063591B2 (en) 2012-10-31
JPWO2007116863A1 (en) 2009-08-20

Similar Documents

Publication Publication Date Title
JP5001158B2 (en) Chemical injection system
JP4925828B2 (en) Chemical injection system
JP4769197B2 (en) Chemical injection system
JP5802713B2 (en) Chemical injection system
JP5063592B2 (en) Chemical injection system
WO2006051856A1 (en) Chemical liquid infusion system
JP4982359B2 (en) Chemical injection system
JP4769198B2 (en) Mechanical system
JP2005131007A (en) Medical fluid injection system
JP5227791B2 (en) Chemical injection device
JP5063590B2 (en) Chemical injection system
WO2007116863A1 (en) Medicinal-liquid injection system

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07740847

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2008509836

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07740847

Country of ref document: EP

Kind code of ref document: A1